Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Hodgkin Disease

fluorodeoxyglucose f18 has been researched along with Hodgkin Disease in 651 studies

Research

Studies (651)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	31 (4.76)	18.2507
2000's	216 (33.18)	29.6817
2010's	313 (48.08)	24.3611
2020's	91 (13.98)	2.80

Authors

Authors	Studies
Bahri, H; Chassagne-Clement, C; Michallet, AS; Mognetti, T; Nicolas-Virelizier, E	1
Jiang, JY; Karikios, D; Lee, ME; Mansberg, R; Parry, NM	1
Bauckneht, M; D'Amico, F; Donegani, MI; Miceli, A; Mora, M; Morbelli, S; Piol, N; Riondato, M; Spina, B	1
Hassan, A; Mufty, S; Razi, M	1
Cheson, BD; Meignan, M	1
Chen, Z; Deng, S; Li, J; Sang, S; Zhou, Y; Zhu, Y	1
Metzger, ML	1
Alonso-Farto, JC; Churruca, J; Durán-Barquero, C; Foncillas, MÁ; Gómez-Fernández, I; González-Gascón-Y-Marín, I; Hernández-Rivas, JÁ; Infante, MS; Landete, E; Marín, K; Muñoz-Novas, C; Ramos-de-Ascanio, V	1
Borchmann, P; Bühnen, I; Diehl, V; Dietlein, M; Eichenauer, DA; Engert, A; Fuchs, M; Kaul, H; Kobe, C; Kreissl, S; Mettler, J; Pabst, T; Voltin, CA	1
Bertinchamp, R; Galicier, L; Gérard, L; Louarn, N; Lussato, D; Merlet, P; Montravers, F; Oksenhendler, É; Vercellino, L	1
Chojnowska, M; Dziuk, M; Gerszewska, M; Gizewska, A; Koza, M; Mazurek, A; Pieczonka, A; Podgajny, Z; Witkowska-Patena, E	1
Sauer, MG	1
Georgi, TW; Kluge, R; Körholz, D; Kornrumpf, K; Kurch, L; Mauz-Körholz, C; Posch, S; Sabri, O; Zieschank, A	1
Balermpas, P; Guninski, RS	1
Buvat, I; Ciarrocchi, A; Ciavarella, S; Cottereau, AS; Donati, B; Durmo, R; Luminari, S; Meignan, M; Merli, F; Nioche, C; Nizzoli, ME; Rebaud, L; Ruffini, A; Vegliante, MC; Versari, A	1
Burton, C; Clark, M; Frangi, AF; Frood, R; Gleeson, F; Patel, C; Scarsbrook, A; Tsoumpas, C	1
Berthelsen, AK; Brown, PN; Loft, A; Maraldo, MV; Meidahl Petersen, P; Nielsen, K; Specht, L; Vogelius, IR	1
Eisazadeh, R; Mirshahvalad, SA	1
Pacella, S	1
Haq, A; Jahromi, AH; Parihar, AS; Wahl, RL	1
Eich, HT; Kobe, C; Oertel, M; Pepper, NB; Rehn, S	1
Al-Ibraheem, A; Almasri, N; Anwer, F; Halahleh, K; Jaradat, I; Juweid, ME; Khalaf, AN; Ma'koseh, M; Mansour, A; Obeidat, S; Shagera, QA	1
Barrington, SF; Dunn, JT; Duran, A; Ilyas, H; Mikhaeel, NG; Mir, N; Subesinghe, M	1
Fendler, WP; Herrmann, K; Pomykala, KL; Seifert, R; Umutlu, L; Vermesh, O	1
Al-Ibraheem, A; Juweid, ME; Mottaghy, FM	1
Akin, EA; Jacene, HA; Merryman, RW; Zeman, MN	1
Amthauer, H; Elgeti, T; Furth, C; Hamm, B; Jensen, LJ; Kim, D; Nagel, SN; Rießelmann, J; Rogasch, JMM; Steffen, IG	1
Bergesio, F; Bianchi, A; Biggi, A; Chauvie, S; Chiaravalloti, A; Fallanca, F; Gallamini, A; Gregianin, M; Guerra, L; La Nasa, G; Menga, M; Patti, C; Pavoni, C; Picardi, M; Rambaldi, A; Romano, A; Schiavotto, C; Schillaci, O; Sorasio, R; Trentin, L; Viviani, S	1
Ansell, SM; Chohan, KL; Habermann, TM; Hoppe, BS; Johnston, PB; Lester, S; Micallef, IN; Moustafa, MA; Rosenthal, A; Tun, HW; Young, JR	1
Akıcı, F; Arslantaş, E; Ayçiçek, A; Bayram, C; Özdemir, N; Özkara, S; Yılmaz, B	1
Alazraki, A; Castellino, SM; Charpentier, AM; Cho, SY; Eutsler, E; Hodgson, DC; Hoppe, BS; Keller, FG; Kelly, KM; Kessel, S; Lai, HA; McCarten, KM; Mhlanga, JC; Pei, Q; Roberts, KB; Voss, SD; Wu, Y	1
Allen, PB; Bazzi, LA; Bryan, LJ; Casulo, C; Chmiel, JS; Dillehay, GL; Gordon, LI; Kane, KL; Karmali, R; Mehta, J; Palmer, BA; Pro, B; Savas, H; Smith, SE; Winter, JN	1
Barrington, SF; Georgi, TW; Hasenclever, D; Kluge, R; Kurch, L; Pike, L; Radford, J; Sabri, O; Warbey, VS	1
Ahmadi Bidakhvidi, N; Deroose, CM; Janssens, A; Vanerwegen, E; Vergote, VKJ	1
Attarbaschi, A; Beishuizen, A; Buerke, B; Cepelova, M; Ceppi, F; Damek, A; Dieckmann, K; Fernández-Teijeiro, A; Fosså, A; Franke, FC; Georgi, TW; Hasenclever, D; Hraskova, A; Karlen, J; Klekawka, T; Kluge, R; Körholz, D; Kurch, L; Landman-Parker, J; Leblanc, T; Mauz-Körholz, C; Moellers, M; Steglich, J; Stoevesandt, D; Uyttebroeck, A; Vordermark, D; Wallace, WH; Wohlgemuth, WA	1
Bernatz, S; Bochennek, K; Fischer, S; Grünewald, L; Grünwald, F; Koch, V; Lehrnbecher, T; Mahmoudi, S; Rosbach, N; Vogl, TJ	1
Kanoun, S	1
Boellaard, R; Driessen, J; Eertink, JJ; Heymans, MW; Kersten, MJ; Moskowitz, AJ; Moskowitz, CH; Schöder, H; Zijlstra, JM; Zwezerijnen, GJC	1
Gallamini, A; Gastaud, L; Kurlapski, M; Sudria, A	1
Beyhan Sagmen, S; Comert, S; Doğan, C; Fidan, A; Kıral, N; Küçüköz Uzun, A; Torun Parmaksız, E; Turan Erkek, E; Yılmaz Haksal, Ç; Yılmaz, G	1
d'Amore, F; Gormsen, LC; Pedersen, MA	1
Hernández-Cruz, M; López-Colombo, A; Montiel-Jarquín, ÁJ; Ruiz-Eng, R; Vargas-Partida, T; Vázquez-Cruz, E	1
Adams, HJA; Kwee, TC	17
Ansell, SM; Botto, B; Habermann, TM; Inwards, DJ; Johnston, PB; Micallef, IN; Novo, M; Nowakowski, GS; Ristow, KM; Vitolo, U; Witzig, TE; Young, JR	1
Hutchings, M	4
Lopci, E; Meignan, M	1
Lijun, Z; Xiao-Xue, W; Xinyue, H	1
Dabaja, B	1
Yahalom, J; Yang, JC	1
Brauer, T; Hoberück, S; Hoffmann, RT; Kotzerke, J; Platzek, I; Winzer, R; Zöphel, K	1
Bonfichi, M; Botto, B; Broccoli, A; Dona, M; Evangelista, A; Gioia, D; Gotti, M; Kovalchuk, S; Mannelli, L; Nassi, L; Pagani, C; Puccini, B; Pulsoni, A; Re, A; Rigacci, L; Salvi, F; Santoro, A; Spina, M; Stelitano, C; Zinzani, PL	1
Bailly, C; Bodet-Milin, C; Carlier, T; Kraeber-Bodéré, F; Le Gouill, S	1
Alsayed, Y; Edesa, W; Hussein, M; Kandeel, AA; Younis, J; Zidan, L	1
Engert, A; Gillessen, S; Kobe, C; von Tresckow, B	1
Altındal, Ş; Aslan, C; Çermik, TF; Doğu, MH; Eren, R; Gündoğan, C; Koç, A; Suyanı, E; Yokuş, O	1
Bösmüller, H; Federmann, B; Fritz, J; Horger, M; Reinert, CP; Sökler, M; Wanek, L	1
Bordenave, L; Bouabdallah, K; Hindié, E; Mesguich, C; Milpied, N	1
Abbott, L; Davila, J; Dinning, S; Kapoor, C; Miller, E; Shapira-Zaltsberg, G; Smith, B; Trejo Perez, E; Wilson, N	1
Diepstra, A; Glaudemans, AWJM; Kluin-Nelemans, HC; Nijland, M; Plattel, WJ; van den Berg, A; van Imhoff, GW; van Meerten, T; Visser, L	1
Bakst, RL; Campbell, BA; Pinnix, CC	1
Cebryk, R; Chaber, R; Koptiuk, O; Kuczyński, K; Kwaśnicka, J; Olchowy, A; Olchowy, C; Pogodajny, Z; Popecki, P; Zaleska-Dorobisz, U; Łach, K; Łasecki, M	1
Scott, JA; Wang, Y	1
Albano, D; Bertagna, F; Giubbini, R; Mazzoletti, A; Muzi, C; Pagani, C; Rossetti, C; Spallino, M; Tucci, A; Zilioli, VR	1
Cappuccio, I; Del Vecchio, S; Della Pepa, R; Fonti, R; Giordano, C; Mainolfi, C; Mascolo, M; Nicolai, E; Pane, F; Picardi, M; Pugliese, N; Rascato, MG; Salvatore, M; Troncone, G; Venetucci, P; Vigliar, E	1
Alessandrino, F; Kalisz, K; Levine, I; Ramaiya, NH; Smith, DA; Tirumani, SH	1
Amarelli, C; Belfiore, MP; Cappabianca, S; Casale, B; Ciccozzi, M; Creta, M; DE Rimini, ML; Maiello, C; Reginelli, A; Sagnelli, C; Sagnelli, E; Sica, A; Spada, A; Troiani, T	1
Çıtak, EÇ; Özcan, PP; Sağcan, F; Tezol, Ö	1
Amin, R; Grinblat, L; Husain, M	1
Bar-Shalom, R; Dann, EJ; Goldschmidt, N; Paltiel, O; Raviv Sharabi, G; Rechavi, T; Trachtenberg, E; Tzemach, R	1
Beishuizen, A; Cho, S; Flerlage, JE; Hagleitner, MM; Kelly, KM; Kluge, R; Kurch, L; Mauz-Koerholz, C; Metzger, ML; Voss, SD	1
Bund, C; Chaban, V; Guffroy, B; Herbrecht, R; Simand, C	1
Albornoz Almada, MC; Boulvard Chollet, XLE; Cabrera Villegas, A; Colletti, PM; Delgado Bolton, RC; Garrastachu, P; Ramírez Lasanta, R; Romero Robles, LG; Rubello, D	1
Berthelsen, AK; de Nully Brown, P; Loft, A; Maraldo, MV; Nielsen, K; Petersen, PM; Specht, L; Vogelius, IR	1
De Alarcon, PA; Flerlage, JE; Hoppe, BS; Kaste, SC; Kelly, KM; Kurch, L; Marks, LJ; Mauz-Koerholz, C; McCarten, K; Metzger, ML; Punnett, A; Seelisch, J; Stroevesandt, D; Voss, SD	1
Albano, D; Bertagna, F; Crucitti, L; Giubbini, R; Mazzoletti, A; Muzi, C; Pagani, C; Re, A; Rossetti, C; Tucci, A; Zilioli, VR	1
Beishuizen, A; Bruin, MCA; de Keizer, B; de Lange, C; Elias, SG; Enríquez, G; Granata, C; Greer, MC; Kwee, TC; Littooij, AS; Miller, E; Nievelstein, RAJ; Sábado, C; Spijkers, S; Tolboom, N; van de Brug, T; Verzegnassi, F	1
Friedberg, J; Li, H; Schoder, H; Stephens, DM	1
Bas, V; Baysal, M; Demir, AM; Demirci, U; Durmus Altun, G; Karaman Gulsaran, S; Kirkizlar, HO; Korkmaz, U; Umit, EG	1
Cuvilliers, C; Girard, A; Meneret, P; Palard-Novello, X; Pontoizeau, C	1
Doroudinia, A; Hosseini, M; Mehrian, P; Rouhizadeh, A	1
Ankrah, AO; Lawal, IO; Lengana, T; Mokoala, KMG; Orunmuyi, AT; Popoola, GO; Sathekge, MM	1
Dührsen, U; Georgi, TW; Hasenclever, D; Hüttmann, A; Kluge, R; Kurch, L; Rekowski, J; Sabri, O; Schmitz, C	1
Berti, V; Kovalchuk, S; Linguanti, F; Puccini, B; Puccini, G; Rigacci, L; Sciagrà, R; Tutino, F	1
Alonso, O; Castillo, LA; Cuña, EG; González-Sprinberg, GA; Pages, C; Rodríguez Taroco, MG; Schelotto, M	1
Attarbaschi, A; Bartelt, JM; Beishuizen, A; Cepelova, M; Ceppi, F; Daw, S; Dieckmann, K; Fernández-Teijeiro, A; Fosså, A; Georgi, TW; Hasenclever, D; Hoffmann, M; Hraskova, A; Karlen, J; Klekawka, T; Kluge, R; Körholz, D; Krombach, G; Kunze, C; Kurch, L; Landman-Parker, J; Leblanc, T; Løndalen, AM; Mauz-Körholz, C; Pears, J; Pelz, T; Plößl, S; Sabri, O; Steiner, D; Stoevesandt, D; Uyttebroeck, A; Vordermark, D; Wallace, WH; Wohlgemuth, WA	1
Kim, K; Kim, SJ	1
Borsatti, E; Burnelli, R; Castello, A; Cistaro, A; Elia, C; Lopci, E; Mascarin, M; Piccardo, A; Zucchetta, P	1
Akhtar, S; Al-Kofide, A; Al-Sweedan, S; Alharthy, H; Almugbel, FA; Elhassan, TAM; Khafaga, Y; Khan, ZA; Maghfoor, I; Osmani, A; Rauf, MS; Zahir, MN	1
Campagna, G; Cappuccio, I; Castaldo, R; Cavaliere, C; Cerchione, C; Della Pepa, R; Franzese, M; Giordano, C; Mascolo, M; Nicolai, E; Pane, F; Picardi, M; Pugliese, N; Rascato, MG; Salvatore, M; Soricelli, A; Troncone, G; Vigliar, E	1
Andersson, PO; Enqvist, O; Krupic, A; Kumar, R; López-Urdaneta, J; Sadik, M; Trägårdh, E; Ulén, J	1
Albano, D; Bertagna, F; Camalori, M; Camoni, L; Coppola, A; Farina, D; Giubbini, R; Muzi, C; Ravanelli, M; Rinaldi, R; Tucci, A; Zilioli, VR	1
Buxton, A; Chen, L; Chirindel, A; Cho, SY; Friedman, DL; Hoppe, BS; Kelly, KM; Kessel, S; Kim, J; Leal, J; McCarten, KM; Milgrom, SA; Pei, Q; Schwartz, CL; Wolden, SL	1
Avigdor, A; Benjamini, O; Kedmi, M; Khaustov, P; Ribakovsy, E	1
Kurihara, H; Makita, S; Tobinai, K	1
Adams, HJ; Kwee, TC	9
Barrington, SF; Kluge, R	1
Georgi, T; Kluge, R; Kurch, L; Metzger, M	1
Zheng, K; Zhuang, H	1
Bouabdallah, K; Hindié, E; Mesguich, C; Milpied, N	2
Laffon, E; Marthan, R	2
Lu, Y; Sanan, P	1
Ankrah, AO; Boshomane, TG; de Wiele, CV; Harry, LM; Lawal, IO; Modiselle, MR; Mokgoro, NP; Msomi, AP; Nyakale, NE; Sathekge, MM	1
Bergesio, F; Bianchi, A; Biggi, A; Chauvie, S; Fallanca, F; Gallamini, A; Gregianin, M; Hutchings, M; Meignan, M; Menga, M	1
Barrington, SF; Johnson, PWM	1
Dann, EJ; Paltiel, O	1
Annunziata, S; Calcagni, ML; Indovina, L; Rufini, V	1
Chen, YH; Jacene, HA; Kamran, SC; Mauch, PM; Ng, AK	1
Barrington, S; Hasenclever, D; Kluge, R; Kurch, L	1
Laskowska-Levy, IP; Markowska, A; Małkowski, B; Wiłkość, M; Wróbel, M; Zając-Lamparska, L	1
Abou Yehia, Z; Akhtari, M; Andraos, TY; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Garg, N; Gunther, J; Khoury, JD; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL; Wogan, CF	1
Maraldo, MV	1
Giraudo, C; Jaeger, U; Karanikas, G; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M	1
Gallamini, A	2
Barras, JL; Burruni, R; Maged, Z; Schaefer, N; Van Der Gucht, A	1
Dabaja, BS; Fanale, M; Gunther, JR; Milgrom, SA; Pinnix, CC	1
Boellaard, R; Zijlstra, JM	1
Ammari, S; Danu, A; Dercle, L; Houot, R; Labaied, N; Lazarovici, J; Marabelle, A; Michot, JM; Mokrane, FZ; Ribrag, V; Schwartz, LH; Seban, RD	1
Lederman, HM; Luisi, FAV; Puchnick, A; Regacini, R	1
Dinh, T; Olshen, AB; Pampaloni, MH; Phelps, AS; Robbins, E; Stieglitz, E	1
Bai, X; Wang, X; Zhuang, H	1
Ammann, RA; Attarbaschi, A; Balwierz, W; Baumann, J; Beishuizen, A; Cepelova, M; Chavdarova, L; Daw, S; Dieckmann, K; Fernández-Teijeiro, A; Fosså, A; Georgi, TW; Hasenclever, D; Hraskova, A; Karlen, J; Kluge, R; Körholz, D; Kurch, L; Landman-Parker, J; Leblanc, T; Mauz-Körholz, C; Pears, J; Pelz, T; Sabri, O; Stoevesandt, D; Uyttebroeck, A; Wallace, WH	1
Abadi-Korek, I; Bernstine, H; Domachevsky, L; Goldberg, N; Groshar, D; Nidam, M; Shpilberg, O	1
Adams, HJA; Alkhawtani, RHM; Balink, H; Glaudemans, AWJM; Huls, G; Kwee, TC; Nijland, M; Noordzij, W; van der Galiën, HT; van Meerten, T; van Rijn, RS	1
Amthauer, H; Furth, C; Hofheinz, F; Hundsdoerfer, P; Rogasch, JMM; Schatka, I; Wedel, F	1
Chaber, R; Kwaśnicka, J; Olchowy, C; Podgajny, Z; Zaleska-Dorobisz, U; Łach, K; Łasecki, M	1
Clifton-Hadley, L; Daw, S; Fitzke, H; Humphries, PD; Klusmann, M; Latifoltojar, A; Lopes, A; Menezes, LJ; Neriman, D; Punwani, S; Shankar, A; Smith, P; Taylor, SA	1
Baech, J; Cheah, CY; El-Galaly, TC; Gormsen, LC; Lo, A; Villa, D	1
Aquino-Parsons, C; Bénard, F; Connors, JM; Farinha, P; Gascoyne, RD; Gerrie, AS; Morris, J; Pickles, T; Savage, KJ; Scott, DW; Sehn, LH; Slack, GW; Tonseth, P; Villa, D; Wilson, D	1
Baues, C; Borchmann, P; Dietlein, M; Drzezga, A; Engert, A; Fuchs, M; Goergen, H; Klaeser, B; Kobe, C; Kreissl, S; Mettler, J; Moccia, A; Oertl, J; Voltin, CA	1
Drachtman, RA; Friedman, DL; Kelly, KM; McCarten, KM; Metzger, ML; Pei, Q; Schwartz, CL	1
Becker, S; Berriolo-Riedinger, A; Casasnovas, O; Édeline, V; Vander Borght, T	1
Édeline, V; Isnardi, V; Remouchamps, V; Vander Borght, T	1
Martires, KJ; Novoa, RA; Tabata, MM	1
Baba, S; Fujita, N; Fukano, R; Kada, A; Kamei, M; Kobayashi, R; Koga, Y; Maeda, N; Mitsui, T; Mori, T; Nakamura, K; Ohki, K; Osumi, T; Saito, AM; Sekimizu, M; Soejima, T; Sunami, S; Tanaka, F; Ueyama, J	1
Bai, X; Wang, X	1
Ankrah, AO; Boshomane, TG; Lawal, IO; Lengana, T; Nyakale, NE; Popoola, GO; Reyneke, F; Sathekge, MM; Vorster, M	1
Bertolini, P; Bianchi, M; Borsatti, E; Buffardi, S; Bunkheila, F; Burnelli, R; Castello, A; Cistaro, A; Elia, C; Fagioli, F; Farruggia, P; Garaventa, A; Guerra, L; Indolfi, P; Lopci, E; Mascarin, M; Moleti, ML; Piccardo, A; Sala, A; Todesco, A; Zucchetta, P	1
Enqvist, O; Lind, E; Polymeri, E; Sadik, M; Trägårdh, E; Ulén, J	1
Badr, S; Elahmadawy, MA; Kotb, M; Moustafa, H	1
Ameri, P; Arboscello, E; Balbi, M; Bauckneht, M; Brunelli, C; Capitanio, S; Congiu, AG; Ghigliotti, G; Marini, C; Miglino, M; Morbelli, S; Sambuceti, G; Sarocchi, M; Spallarossa, P	1
Aigner, R; Ammann, RA; Bartenstein, P; Bengel, FM; Brenner, W; Eggert, A; Feuchtinger, T; Gattenlöhner, S; Georgi, T; Golombeck, M; Hasenclever, D; Klapper, W; Kluge, R; Körholz, D; Krause, T; Kurch, L; Mauz-Körholz, C; Rossig, C; Sabri, O; Schäfers, M; Sykora, KW; Tchavdarova, L; Urban, C	1
Boellaard, R; Borchmann, P; Dietlein, M; Drzezga, A; Kobe, C; Kuhnert, G; Mettler, J; Voltin, CA	1
Bailey, JJ; Brown, RKJ; Hutchinson, RJ; Kaminski, MS; Sedig, LK; Wong, KK	1
Baranska, D; Gorska-Chrzastek, M; Grzelak, P; Krajewska, K; Matera, K; Podgorski, M; Trelinska, J	1
Bagni, O; Biondi, T; Cenfra, N; Cimino, G; Codacci-Pisanelli, G; Filippi, L; Laghi, A; Mecarocci, S; Ortu La Barbera, E; Panebianco, M	1
Chen, TP; Chiu, NT; Lin, YH; Liu, CS; Yi, WL	1
Brice, P; Casasnovas, O; Chen, A; Dercle, L; Ghesquières, H; Houot, R; Manson, G; Mokrane, FZ; Morschhauser, F; Schiano de Colella, JM; Stamatoullas, A	1
Bettinelli, A; Branchini, M; Cecchin, D; De Monte, F; Paiusco, M; Zorz, A; Zucchetta, P	1
Beer, AJ; Cepelova, M; Conrad, E; Erdlenbruch, B; Kewitz-Hempel, S; Kluge, R; Knirsch, S; Kramm, CM; Kurch, L; Odparlik, A; Pöpperl, G; Reinbold, WD; Sabri, O; Sahlmann, CO; Sauerbrey, A; Staege, MS; Steinbach, D; Volkmer, I	1
Barrington, SF; Meignan, M	1
Bair, SM; Svoboda, J	1
Bund, C; Fornecker, LM; Namer, IJ; Noblet, V; Paillard, C; Tauty, A	1
Amini, RM; Andersen, MD; Barrington, SF; d'Amore, AL; d'Amore, F; Enblad, G; Gormsen, LC; Hamilton-Dutoit, S; Johnson, P; Kamper, P; Molin, D; Pedersen, MA; Wassberg, C	1
Deyell, RJ; Eftekhari, A; Ingley, KM; Nadel, HR; Potts, JE; Wilson, DC	1
Bando-Delaunay, A; Cassou-Mounat, T; Huchet, V; Jehanno, N; Luporsi, M	1
Anker, MS; Finke, D; Haberkorn, U; Heckmann, MB; Katus, HA; Lehmann, LH; Müller-Tidow, C; Totakhel, B	1
Chen, YH; Chuang, KS; Hsieh, TC; Lin, HH; Liu, SH; Lue, KH; Wu, YF	1
Sioka, C	1
Böll, B; Eich, HT; Engert, A; Klimm, B; Kriz, J; Müller, RP; Rancea, M; Schmidberger, H	1
Buriánková, E; Flodr, P; Formánek, R; Henzlová, L; Indrák, K; Jarošová, M; Kapitáňová, Z; Mysliveček, M; Papajík, T; Procházka, V; Turcsányi, P; Urbanová, R	1
Araf, S; Montoto, S	1
Abdelsalam, M; Abouzied, M; Akhtar, S; Al-Sugair, AS; Alkadhi, Y; Darwish, A; Dingle, M; Elhassan, TA; Eltigani, A; Maghfoor, I; Nabil-Ahmed, M; Soudy, H	1
Dietlein, M; Drzezga, A; Kahraman, D; Kobe, C; Kuhnert, G; Rothe, A; Sasse, S; Scheid, C; Theurich, S; von Bergwelt-Baildon, M	1
Batra, S; Bhargava, R; Gupta, S; Vaid, AK	1
Gallamini, A; Kostakoglu, L	2
Feng, T; Leiker, AJ; Li, Y; Onar-Thomas, A; Reddick, WE; Reutens, DC; Shan, ZY; Shulkin, BL	1
Khodzhibekova, MM	1
Chong, A; Chung, JS; Hong, JS; Jeong, SY; Kim, JH; Kim, SJ; Lee, JJ; Lee, SM; Moon, JH; Shin, HJ; Song, MK	1
André, MP	1
Hertzberg, M	1
Adams, HJ; de Keizer, B; de Klerk, JM; Fijnheer, R; Kwee, TC; Littooij, AS; Nievelstein, RA	1
Györke, T; Kajáry, K; Lengyel, Z; Molnár, P; Molnár, Z; Szakáll, S	1
Brown, Pde N; Bukh, A; Bøgsted, M; d'Amore, F; El-Galaly, TC; Gormsen, LC; Hutchings, M; Iyer, V; Johnsen, HE; Kamper, P; Loft, A; Mylam, KJ; Nielsen, AL	1
Deroose, CM; Dierickx, D; Gheysens, O; Goffin, K; Tousseyn, T; Verhoef, G	1
Kajáry, K; Lengyel, Z; Molnár, P; Molnár, Z; Szakáll, S	1
Abbatiello, P; Cantonetti, M; Chiaravalloti, A; Danieli, R; Di Pietro, B; Guazzaroni, M; Orlacchio, A; Schillaci, O; Simonetti, G; Travascio, L	1
Bastie, JN; Berriolo-Riedinger, A; Brunotte, F; Casasnovas, RO; Chrétien, ML; Dygai-Cochet, I; Humbert, O; Kanoun, S; Legouge, C; Rossi, C	1
Dhull, VS; Karunanithi, S; Kumar, R; Mukherjee, A; Sharma, P	1
Casasnovas, RO; Coriani, C; Fioroni, F; Gobbi, PG; Itti, E; Luminari, S; Masset, H; Meignan, M; Merli, F; Sasanelli, M; Versari, A	1
Ben-Barak, A; Dann, EJ; Israel, O; Kagna, O; Weiler-Sagie, M	1
Álvarez Fernández-Teijeiro, A; Attarbaschi, A; Beishuizen, A; Bergsträsser, E; Cepelová, M; Elsner, A; Fosså, A; Georgi, T; Hasenclever, D; Hraskova, A; Karlén, J; Kluge, R; Körholz, D; Kurch, L; Landman-Parker, J; Mauz-Körholz, C; Moryl-Bujakowska, A; Pears, J; Sabri, O; Schomerus, E; Uyttebroeck, A; Wallace, H	1
Borra, A; Gallamini, A	1
Altman, JK; Dillehay, GL; Evens, AM; Frankfurt, O; Gentzler, RD; Gordon, LI; Kaminer, L; Mehta, J; Mittal, BB; Petrich, AM; Rademaker, AW; Singhal, S; Variakojis, D; Weitner, BB; Williams, S; Winter, JN	1
Barrington, SF; Biggi, A; Bolis, S; Brice, P; Casasnovas, O; Chauvie, S; Coleman, M; Dann, EJ; Gallamini, A; Gregianin, M; Hofman, MS; Hutchings, M; Kostakoglu, L; Loft, A; Luminari, S; Meignan, M; Mikhaeel, GN; Pulsoni, A; Rigacci, L; Rusconi, C; Salvi, F; Seymour, JF; Trentin, L; Viviani, S; Zaucha, JM	1
Ciancia, G; Cirillo, M; Cozzolino, I; Pane, F; Pettinato, G; Picardi, M; Pugliese, N; Quintarelli, C; Salvatore, C; Zeppa, P	1
Barker, C; Goenka, A; Gonen, M; Kowalski, A; Lim, R; Lovie, S; McCann, P; Schöder, H; Terezakis, SA; Turlakov, A; Yahalom, J	1
Deng, L; Lin, N; Liu, W; Ping, L; Song, Y; Tu, M; Wang, X; Xie, Y; Yang, Z; Ying, Z; Zhang, C; Zheng, W; Zhu, J	1
Abraham, J; Bordessoule, D; Delage-Corre, M; Dmytruk, N; Girault, S; Gourin, MP; Jaccard, A; Labrousse, F; Monteil, J; Moreau, S; Olivrie, A; Preux, PM; Remenieras, L; Touati, M; Turlure, P	1
Bednaruk-Młyński, E; Dzietczenia, J; Kulikowski, W; Leśniewski-Kmak, K; Małkowski, B; Pieńkowska, J; Skórzak, A; Subocz, E; Wróbel, T; Zalewska, M; Zaucha, JM; Zaucha, R	1
Amthauer, H; Bockisch, A; Borchmann, P; Diehl, V; Dietlein, M; Drzezga, A; Eich, HT; Engert, A; Franke, M; Fuchs, M; Haverkamp, H; Kahraman, D; Kluge, R; Klutmann, S; Kobe, C; Kuhnert, G; Maintz, D; Persigehl, T; Wolf, HH	1
Balink, H; Hoogendoorn, M	1
Berenger, N; Brice, P; Brière, J; Grellier, JF; Leblanc, T; Merlet, P; Thieblemont, C; Toubert, ME; Vercellino, L; Weinmann, P	1
Evens, AM; Kostakoglu, L	3
Andersen, FL; Aznar, MC; Berthelsen, AK; Josipovic, M; Klausen, TL; Loft, A; Maraldo, M; Petersen, PM; Schut, DA; Specht, L	1
Alberini, JL; Aupérin, A; Bonniaud, G; Celebic, A; Edeline, V; Elleuch, M; Fermé, C; Girinsky, T; Ribrag, V; Ruelle, C	1
Biggi, A; Coleman, M; Czuczman, MS; Danielewicz, I; Diehl, L; Hutchings, M; Kostakoglu, L; Lamonica, D; Loft, A; Malkowski, B; Nanni, C; Specht, L; Stern, R; Zaucha, JM; Zinzani, PL	1
Hasenclever, D; Kluge, R; Kurch, L	1
Barrington, SF; Cavalli, F; Cheson, BD; Fisher, RI; Lister, TA; Schwartz, LH; Zucca, E	1
Cantonetti, M; Caracciolo, CR; Chiaravalloti, A; Danieli, R; Gallamini, A; Guazzaroni, M; Orlacchio, A; Schillaci, O; Simonetti, G; Travascio, L	1
Behnia, S; Cassaday, RD; Gopal, AK; Graf, SA; Green, DJ; Holmberg, L; Libby, EN; Maloney, DG; Onishi, M; Pagel, JM; Philip, M; Press, OW; Roden, JE; Schiavo, K; Shustov, AR; Smith, SD; Till, BG	1
Bianchi, M; Cistaro, A; Coppolino, P; Cucinotta, M; Fagioli, F; La Delfa, V; Quartuccio, N	1
Chen, Q; Chen, W; Dilsizian, V; Kim, J; Kimball, AS; Resnik, C	1
Beschorner, R; la Fougère, C; Pichler, B; Reischl, G; Schwenck, J; Skardelly, M; Tabatabai, G	1
Blasco, H; Colombat, P; Eder, V; Iltis, A; Sénécal, D	1
de Clermont, H; Laffon, E; Lamare, F; Marthan, R	1
Chiaravalloti, A; Schillaci, O	1
Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA	2
Iida, S; Inagaki, H; Ishida, T; Kusumoto, S; Masaki, A; Mori, F; Suzuki, T	1
Dieckmann, K; Kluge, R; Körholz, D; Mauz-Körholz, C; Vordermark, D	1
El-Rabadi, K; Georgios, K; Karanikas, G; Karem, el-R; Knogler, T; Marius Erik, M; Mayerhoefer, ME; Michael, W; Thomas, K; Weber, M	1
Dunleavy, K; Wilson, WH	1
Johnson, P; McKenzie, H	1
Borchmann, P; Engert, A; Kobe, C; Sickinger, MT; Skoetz, N; von Tresckow, B	1
Baldassarre, F; Cheung, MC; Crump, M; Herst, J; Hodgson, D; MacEachern, J; Sussman, J	1
Bennani-Baiti, B; Bennani-Baiti, N; Flynt, L; Yadav, S	1
Aldred, VL; Buccheri, V; Cerci, JJ; de Paula, HM; Gonçalves, Mde C; Linardi, Cda C; Siqueira, SA; Zerbini, MC	1
Dolak, W; Jaeger, U; Karanikas, G; Kiesewetter, B; Kletter, K; Knogler, T; Lukas, J; Mayerhoefer, ME; Müllauer, L; Porpaczy, E; Prosch, H; Raderer, M; Sillaber, C; Simonitsch-Klupp, I; Skrabs, C; Ubl, P; Weber, M	1
Gandikota, N; Hartridge-Lambert, S; Migliacci, JC; Portlock, CS; Schöder, H; Yahalom, J	1
Akhtar, S; Alhuraiji, A	1
Johnson, PW; Remer, M	1
Baues, C; Dietlein, M; Eich, HT; Engenhart-Cabillic, R; Engert, A; Haverkamp, H; Haverkamp, U; Hegerfeld, K; Herfarth, K; Kobe, C; Kriz, J; Kuhnert, G; Lukas, P; Reinartz, G; Schmidberger, H; Staar, S	1
Adams, HJ; Kwee, TC; Nievelstein, RA	2
Cavalli, F; Ceriani, L; Griguolo, G; Mazzucchelli, L; Stathis, A; Zucca, E	1
Carlos Herrera, J; Chen-Liang, TH; Contreras, J; Cozar, Mdel P; Fernandez-Gonzalez, M; Fernandez-Muñoz, H; Frutos, L; Igua, C; Jerez, A; Lancharro, A; Luis Navarro, J; Martin-Santos, T; Muiña, B; Orero, MT; Ortuño, FJ; Perez-Ceballos, E; Raya, JM; Remigia, MJ; Romera, M; Sanchez-Blanco, JJ; Sanchez-Vaño, R; Senent, L; Uña, J; Villegas, C	1
Colombié, M; Goineau, A; Rousseau, C; Sadot-Lebouvier, S; Supiot, S	1
Bordenave, L; Colletti, PM; Gordien, P; Guyot, M; Hindié, E; Morliere, C; Rubello, D	1
Botto, B; Buglione, M; Ciammella, P; Filippi, AR; Iotti, C; Livi, L; Magrini, SM; Merli, F; Re, A; Ricardi, U; Saieva, C; Simontacchi, G; Vaggelli, L	1
Chang, CA; Kumar, B; Nandurkar, D	1
Nagata, K; Niitsu, N; Sakai, J; Takahashi, N; Tamaru, J; Tanae, K; Yoshino, T	1
Advani, RH; Hoppe, RT; Iberri, DJ	1
Abruzzese, E; Bocchia, M; Bono, R; Bosi, A; Cencini, E; Cox, MC; Di Lollo, S; Di Napoli, A; Fabbri, A; Fratoni, S; Gini, G; Goteri, G; Kovalchuk, S; Lazzi, S; Leoncini, L; Mancuso, S; Rigacci, L	1
Bongioanni, F; Buschiazzo, A; Capitanio, S; De Astis, E; De Carli, F; Fiz, F; Marini, C; Miglino, M; Morbelli, S; Pomposelli, E; Sambuceti, G; Verardi, MT	1
Asabella, AN; Brunese, L; Calabrese, A; de Fazio, V; De Tullio, G; Ferrari, C; Ficco, M; Guarini, A; Loseto, G; Maggialetti, N; Minoia, C; Rubini, G	1
Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Heggelman, BG; Kwee, TC; Nievelstein, RA	1
Attili, A; Chiaravalloti, A; Duggento, A; Guerrisi, MG; Schillaci, O; Strigari, L	1
Ciammella, P; Filippi, AR; Ricardi, U; Simontacchi, G	1
Adams, HJA; Kwee, TC; Nievelstein, RAJ	1
Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A	1
Abbou, S; Balogova, S; Ducou-Lepointe, H; Jorgov, L; Landman-Parker, J; Leblanc, T; Montravers, F; Pacquement, H; Ragu, C; Talbot, JN	1
Li, P; Liu, Q; Lu, J; Luo, H; Song, S; Wang, C; Wu, S	1
Almquist, H; Barrington, SF; Berkahn, L; Brun, E; D'Amore, F; Federico, M; Fosså, A; Franceschetto, A; Fulham, MJ; Hjorthaug, K; Johnson, PW; Kirkwood, AA; Luminari, S; Molin, D; O'Doherty, MJ; Pike, LC; Radford, J; Roberts, TH; Sinclair, DA; Smith, P; Stevens, L; Trotman, J; Viney, ZN	1
Annunziata, S; Bartolomei, F; Calcagni, ML; Cuccaro, A; Cupelli, E; D'Alò, F; Galli, E; Giachelia, M; Giordano, A; Hohaus, S; Larocca, LM; Leone, G; Martini, M; Rufini, V; Voso, MT	1
Dolak, W; Giraudo, C; Karanikas, G; Kiesewetter, B; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M	1
Evangelista, L; Pasquale, R	1
Caocci, G; Carcassi, C; Caria, R; Celeghini, I; Di Raimondo, F; Gallamini, A; Greco, M; La Nasa, G; Lai, S; Littera, R; Martino, M; Oppi, S; Porcella, R; Romano, A	1
Bisi, G; Botto, B; Buglione, M; Ciammella, P; Filippi, AR; Iotti, C; Mangoni, M; Marcheselli, L; Merli, F; Ricardi, U; Simontacchi, G; Versari, A	1
Barr, PM; Bartlett, NL; Cheson, BD; Cook, JR; Evens, AM; Fanale, MA; Fisher, RI; Friedberg, JW; Gascoyne, RD; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Lechowicz, MJ; Leonard, JP; Li, H; Mittra, ES; Moskowitz, CH; Noy, A; Press, OW; Rimsza, LM; Schöder, H; Straus, DJ; Sweetenham, JW	1
Goineau, A; Supiot, S	1
Ben Taylor, M; Bishton, MJ; Bloor, AJC; Chakraverty, R; Fielding, AK; Fox, CP; Kayani, I; Mackinnon, S; Morris, EC; Peggs, KS; Reyal, Y; Russell, N; Sjursen, AM; Thomson, KJ	1
Cheson, BD; Cordova, C; Esposito, G; Hill, EM; Nassif, S; Ozdemirli, M; Ujjani, CS; Wang, H	1
Bacanovic, S; Burger, IA; Huellner, MW; Pircher, M; Stiller, R	1
Madhavan, R; Sathiyasekaran, M; Satish, G; Scott, JX; Srinivasan, A	1
Bongioanni, F; Fazio, V; Giannini, EG; Moscatelli, A; Nero, LD; Pellegatta, G; Sambuceti, G; Savarino, V	1
Abramson, JS; Arabasz, G; Atkinson, W; Barnes, J; Blake, MA; Catalano, O; Catana, C; Guimaraes, AR; Hochberg, E; McDermott, S; Muse, V; Rosen, BR; Shelly, M	1
Biner, IU; Gokcek, A; Ozmen, O; Sahin, G; Tanyildiz, HG; Tatci, E; Tazeler, Z	1
Afaq, A; Ardeshna, KM; Babikir, S; Ganeshan, B; Groves, AM; Kayani, I; Miles, KA; Shortman, R	1
Danilov, AV; Friedberg, JW; Li, H; Noy, A; Press, OW; Reid, E; Shapira, I; Smith, SM; Swinnen, LJ	1
Bordenave, L; Bouabdallah, K; Cazeau, AL; Guyot, M; Hindié, E; Mesguich, C; Milpied, N; Soubeyran, P	1
Chen, Y; Huang, Z; Shao, F; Wu, J; Zhou, F	1
Federico, M; Johnson, P; Trotman, J	1
Afaq, A; Akin, O; Ardeshna, K; Chen, SH; Fraioli, F; Groves, A; Kayani, I; Lambert, J; Linch, D; Miles, K; Punwani, S; Sidhu, H; Wan, S	1
Meignan, M	1
Balogova, S; Jorgov, L; Landman-Parker, J; Montravers, F; Talbot, JN	1
Georgi, T; Hasenclever, D; Kluge, R; Kurch, L	1
Baldessari, C; Baldini, L; Bari, A; Cox, MC; Federico, M; Ferri, P; Gobbi, P; Marcheselli, L; Marcheselli, R; Musto, P; Pozzi, S; Sacchi, S; Tadmor, T	1
Harada, S; Machida, H; Naruse, K; Shinohara, T	1
Terauchi, T	1
Barrington, SF; Burggraaff, CN; Kersten, MJ; Zijlstra, JM	1
Bakhshi, S; Bhethanabhotla, S	1
Dony, A; Dubreuil, J; Giammarile, F; Salles, G; Skanjeti, A; Traverse-Glehen, A	1
Akhtari, M; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Garg, N; Gunther, JR; Khoury, JD; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL; Suki, T; Yehia, ZA	1
Casasnovas, RO; Rossi, C	1
Cheson, BD; Kostakoglu, L	1
Bouabdallah, K; Cazeau, AL; Hindié, E; Mesguich, C	1
Bolis, S; Borra, A; Canepari, M; Cantonetti, M; Darcourt, J; El-Galaly, TC; Ettaiche, M; Gallamini, A; Kulikowski, W; Luminari, S; Malkowski, B; Ouvrier, MJ; Rigacci, L; Rusconi, C; Salvi, F; Subocz, E; Tajer, J; Trentin, L; Viotti, J; Viviani, S; Zaucha, JM; Zwarthoed, C	1
Altini, C; De Leonardis, F; Fanelli, M; Ferrari, C; Merenda, N; Muggeo, P; Niccoli Asabella, A; Perillo, T; Rubini, G; Santoro, N	1
Bölükbaşı, Y; Çetiner, M; Demirkol, O; Falay, O; Ferhanoğlu, B; Gümüş, T; Örnek, S; Özbalak, M; Öztürk, E	1
Dickinson, M; Hofman, M; Irving, L	1
Crump, M	1
Cousins, J; Currie, G; Czachowski, M; Muthukrishnan, A	1
Bartlett, NL	1
Aleman, B; Bonniaud, G; Edeline, V; Ghalibafian, M; Girinsky, T; Lievens, Y; Meijnders, P; Noordijk, E; Paumier, A; Poortmans, P; Specht, L; Van Der Maazen, R	1
Erturk, SM; Van den Abbeele, AD	1
Ambrosini, V; Castellucci, P; Fanti, S; Franchi, R; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Zinzani, PL	1
Cheson, BD	2
Bonardel, G; Coindre, JM; Foehrenbach, H; Gontier, E; Mantzarides, M; Schlaifer, D; Soret, M	1
Castellucci, P; Egesta, L; Fanti, S; Golemi, A; Grassetto, G; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Tsamita, CS; Zinzani, PL	1
Amthauer, H; Bares, R; Bockisch, A; Borchmann, P; Diehl, V; Dietlein, M; Eich, HT; Engert, A; Franklin, J; Fuchs, M; Klutmann, S; Knapp, WH; Kobe, C; Lohri, A; Lorenz, R; Markova, J; Mueller, RP; Schicha, H; Schreckenberger, M; Weckesser, M; Zijlstra, JM	1
Kostakoglu, L	2
Il'in, NV; Ivanova, AA; Ivanova, EI; Ryzhkova, DV; Savchenko, ON; Tiutin, LA; Tlostanova, MS; Vinogradova, IuN	1
Borchmann, P; Dietlein, M; Engert, A; Kluge, R; Kobe, C; Mauz-Körholz, C; Sabri, O; Schicha, H; Schober, O	1
Radford, J	1
Brepoels, L; Stroobants, S	2
Ambrosini, V; Biassoni, L; Burnelli, R; Castellucci, P; Fanti, S; Lopci, E; Nanni, C; Rubello, D	1
Aydoğan, A; Berberoğlu, K; Corapcioglu, F; Doğan, S; Klç, SC; Oncel, S	1
Dedeckova, K; Dietlein, M; Eich, HT; Engert, A; Klaskova, K; Kobe, C; Kozak, T; Markova, J; Plütschow, A; Skopalova, M	1
Bardet, S; Couturier, O; Hotta, T; Hutchings, M; Lau, J; Nagai, H; Nihashi, T; Terasawa, T	1
Anastasia, A; Balzarotti, M; Bramanti, S; Castagna, L; Chiti, A; Giordano, L; Magagnoli, M; Mazza, R; Nozza, A; Rinifilo, E; Rodari, M; Santoro, A; Sarina, B; Todisco, E	1
Allen-Auerbach, M; Weber, WA	1
De Laurentiis, M; Grimaldi, F; Nicolai, E; Pane, F; Picardi, M; Rotoli, B; Soricelli, A; Zeppa, P	1
Kim, H; Kim, SE; Lee, WW; Park, SY; Shim, HK	1
Assanelli, A; Bregni, M; Ciceri, F; Crocchiolo, R; Fallanca, F; Fazio, F; Ferreri, AJ; Gianolli, L; Giovacchini, G; Pescarollo, A; Ponzoni, M; Verona, C	1
Carrère, MO; Giammarile, F; Morelle, M; Pommier, P; Remonnay, R	2
Berthou, C; Bodet-Milin, C; Cambefort, P; Campion, L; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S; Moreau, A; Moreau, P; Salaun, PY	1
Priola, AM; Priola, SM	1
Dufault, DL; Dunphy, CH; Ivanovic, M; Khandani, AH; Meteesatien, P; Shea, TC	1
Huchet, V; Kerrou, K; Montravers, F; Pascal, O; Talbot, JN	1
Czerminski, J; LaCasce, AS; Mauch, PM; Ng, AK; Sher, DJ; Van Den Abbeele, A	1
Buccheri, V; Cerci, JJ; Linardi, Cda C; Meneghetti, JC; Pracchia, LF; Soares Junior, J	1
Fan, W; Ma, LF	1
Ansquer, C; Durant, C; Hamidou, M; Hervier, B; Masseau, A	1
Bhalla, KN; Bishton, M; DeAngelo, DJ; Dickinson, M; Fischer, T; Liu, A; Ottmann, OG; Parker, K; Prince, HM; Ritchie, D; Scott, JW; Spencer, A	1
Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Hundsdoerfer, P; Kobe, C; Misch, D; Ruf, J; Schönberger, S; Steffen, IG; Stöver, B	1
Chioléro, R; Duchosal, MA; Pascual, M; Pilon, N; Prior, JO; Schmidt, S; Turini, P	1
Bourland, W; Garrington, T; Grunzke, M; Hayes, K	1
de Haas, M; de Klerk, J; Fijnheer, R; Hoekstra, O; Kramer, M; Quarles van Ufford, H; Tieks, B; Wittebol, S	1
Conti, PS; de Kerviler, E; Delbeke, D; Gisselbrecht, C; Meignan, M; Stroobants, S	1
Martin, P	1
Nagai, H; Terasawa, T	1
Fiore, F; Gallamini, A; Meignan, M; Sorasio, R	1
Goodin, GS; Hudson, MM; Kaste, SC; Krasin, MJ; McCarville, MB; Metzger, M; Shulkin, BL	1
Borbényi, Z; Deák, B; Galuska, L; Illés, A; Keresztes, K; Marton, I; Miltényi, Z; Molnár, Z; Rosta, A; Schneider, T; Simon, Z; Trón, L; Várady, E	2
Hany, TF; Knuth, A; Mischo, A; Petrausch, U; Renner, C; Samaras, P; Schaefer, NG; Soyka, JD; Tschopp, A; Veit-Haibach, P	1
Kuruvilla, J	1
Okamoto, R	1
Kalkanis, DG; Paes, FM; Serafini, AN; Sideras, PA	1
Gupta, AK; Kandasamy, D; Seth, R	1
Dietlein, M; Fuchs, M; Kobe, C	1
Bilici, A; Canpolat, N; Gumus, M; Kefeli, U; Ozdemir, N; Salepci, T; Seker, M; Ustaalioglu, BB; Ustaalioglu, R; Yıldirim, E; Yilmaz, BE	1
Marchiori, E; Mauro Mano, C; Zanetti, G	1
Moskowitz, CH; Schoder, H; Zelenetz, A	1
Anitei, M; Bénamor, M; Brice, P; Brière, J; Cuenca, X; de Kerviler, E; Decaudin, D; Filmont, JE; Hindié, E; Moretti, JL; Moulin-Romsee, G; Sibon, D	1
Cammilleri, S; Hindié, E; Jan, S; Mundler, O; Taieb, D; Trébossen, R; Zanotti-Fregonara, P	1
Aström, G; Hagberg, H; Molin, D; Suurküla, M	1
Avivi, I; Bar-Shalom, R; Ben-Shachar, M; Dann, EJ; Epelbaum, R; Gaitini, D; Rowe, JM; Tamir, A	1
Haerle, SK; Hälg, RA; Huber, GF; Schaefer, N; Schrepfer, T; Strobel, K	1
Glass, JO; Mateja, SJ; Reddick, WE; Shan, ZY; Shulkin, BL	1
Artignan, X; Beckendorff, V; Bondiau, PY; Carrie, C; Chabaud, S; D'Hombres, A; Dussart, S; Giammarile, F; Girinsky, T; Lagrange, JL; Nguyen, TD; Pommier, P	1
Aquino, SL; Crowley, D; Feng, Y; Hochberg, EP; Lacasce, AS; Lee, AI; Neuberg, DS; Toomey, C; Van den Abbeele, AD; Zuckerman, DS	1
Blouet, A; Courbon, F; David, I; Filleron, T; Izar, F; Laprie, A; Metwally, H; Plat, G; Rives, M; Robert, A; Vial, J; Zerdoud, S	1
Anderson, CS; Esiashvili, N; Goodman, M; Halkar, R; Keller, FG; Marcus, RB; Robertson, VL	1
Gallamini, A; Grimaldi, F; Nicolai, E; Pane, F; Picardi, M; Soricelli, A	1
Fabbri, A; Forconi, F; Gozzetti, A; Lauria, F	1
Derbekyan, V; Lisbona, R; Makis, W	1
Goldschmidt, N; Klein, M; Or, O; Paltiel, O; Savitsky, B	1
Exarhos, DN; Karmiris, T; Michelis, FV; Nikiforakis, E; Tzannou, IA	1
Buccheri, V; Cerci, JJ; Delbeke, D; Izaki, M; Linardi, CC; Meneghetti, JC; Pitella, FA; Pracchia, LF; Soares, J; Trindade, E	1
Barrington, SF; Johnson, P; MacKewn, JE; Marsden, PK; Mikhaeel, NG; Mouncey, P; O'Doherty, MJ; Patrick, P; Popova, B; Qian, W; Radford, J; Schleyer, P	1
Borchmann, P; Dietlein, M; Eich, HT; Engert, A; Fuchs, M; Furth, C; Kobe, C; Kriz, J	1
Beaven, A; Broadwater, G; Chao, N; Coleman, RE; Goggins, T; Horwitz, M; Palmer, J; Rizzieri, D; Sullivan, K	1
Alarcon, Pd; Chen, L; Cole, PD; Drachtman, RA; McCarten, KM; Schwartz, CL; Trippett, TM	1
Gönen, M; Gonzales, AM; Hunt, MA; Kirov, AS; Kowalski, A; McCann, P; Reiner, A; Schmidtlein, CR; Schöder, H; Terezakis, SA; Yahalom, J	1
Amati, A; Arena, V; Bellò, M; Bisi, G; Douroukas, A; Passera, R; Pelosi, E; Penna, D	1
Blin, N; Bodere-Kraeber, F; Bodet-Milin, C; Dubruille, V; Gastinne, T; Le Gouill, S; Le Roux, PY; Mahe, B; Nowak, E; Querellou, S; Salaun, PY	1
Juweid, ME	2
Bérczi, V; Bodó, I; Bottlik, G; Garai, I; Györke, T; Kollár, A; Masszi, T; Szepesi, Á	1
Cermik, TF; Ciftçi, H; Ergül, N; Güner, SI; Huq, GE; Sağer, S	1
Ramsdale, E; Smith, SM; van Besien, K	1
Akdemir, ÖÜ; Aki, Z; Kapucu, ÖL; Özkurt, ZN; Sucak, GT; Suyani, E; Yağci, M; Yaşar, DG; Yeğin, ZA	1
Fijnheer, R; Kersten, MJ; Kwee, TC; Nievelstein, RA; van Leeuwen, MS; Vermoolen, MA	1
Alavi, A; Chamroonrat, W; Chen, W; Cheng, G; Torigian, DA; Zhuang, H	1
Biondi, S; Buffardi, S; Burnelli, R; Casale, F; Cistaro, A; Derenzini, E; Fanti, S; Farruggia, P; Garaventa, A; Guerra, L; Indolfi, P; Lopci, E; Pession, A; Piccardo, A; Sala, A; Schumacher, F; Todesco, A; Zucchetta, P	1
Brambilla, M; Della Monica, P; Inglese, E; Krengli, M; Loi, G; Matheoud, R; Vigna, L	1
Abboud, CN; Bartlett, NL; Cashen, AF; Dehdashti, F; Dipersio, JF; Fehniger, TA; Homb, A; Smeltzer, JP; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Westervelt, P; Zhang, Q	1
Bagni, B; Cesaretti, M; Cuneo, A; De Lisi, V; Federico, M; Ferretti, S; Guida, A; Luminari, S; Mangone, L; Merli, F; Postiglione, R; Re, F; Ruffini, L; Tomasello, C; Versari, A	1
Böll, B; Dedeckova, K; Dietlein, M; Eich, HT; Kahraman, D; Klaskova, K; Kobe, C; Kozak, T; Markova, J; Mocikova, H; Skopalova, M	1
Bhattacharya, A; Das, R; Kashyap, R; Malhotra, P; Manohar, K; Mittal, BR; Varma, N; Varma, S	1
Dyer, MJ; Entwisle, J; Harman, KE; Simpson, RC	1
Buccheri, V; Celli, M; Cerci, JJ; Coutinho, AM; Delbeke, D; Fanti, S; Linardi, CC; Meneghetti, JC; Pitela, FA; Pracchia, LF; Soares, J; Trindade, E; Zanoni, L; Zinzani, PL	1
Amthauer, H; Becker, M; Ehlert, K; Haberkorn, U; Hasenclever, D; Hundsdörfer, P; Kluge, R; Körholz, D; Kranert, WT; Krausse, A; Kulozik, AE; Mauz-Körholz, C; Purz, S; Rössler, J; Ruschke, K; Sabri, O; Schober, O; Sorge, I; Stiefel, M; Weber, WA	1
Chiang, S; Dreyer, Z; Margolin, J; Paulino, AC; Teh, BS	1
Sweetenham, JW	1
McNamara, CJ; Ramsay, A; Richardson, SE; Sudak, J; Warbey, V	1
Argnani, L; Baccarani, M; Broccoli, A; Castagnoli, A; Fanti, S; Puccini, B; Rigacci, L; Stefoni, V; Vaggelli, L; Zanoni, L; Zinzani, PL	1
Dastidar, P; Eskola, H; Järvenpää, R; Kellokumpu-Lehtinen, PL; Korkola, P; Pertovaara, H; Rossi, M; Soimakallio, S; Wu, X	1
Kluge, R; Körholz, D	1
Ardeshna, K; D'Sa, S; Marzolini, M; Padhani, A; Wong, WL	1
Shi, M; Wang, J	1
Gerecitano, J; Hamlin, P; Horwitz, S; Maragulia, JC; Matasar, MJ; Moskowitz, AJ; Moskowitz, CH; Nimer, SD; Noy, A; Palomba, L; Perales, MA; Portlock, C; Schoder, H; Straus, D; Yahalom, J; Zelenetz, AD	1
Amthauer, H; Denecke, T; Furth, C; Großer, O; Hautzel, H; Henze, G; Hofheinz, F; Hundsdoerfer, P; Meseck, RM; Ruf, J; Schoenberger, S; Steffen, IG	1
Bashir, H; Faruqui, ZS; Maaz, AU; Mahmood, MT; Mian, M; Mufti, KA; Munir, I; Muzahir, S; Nawaz, MK; Siddiqui, N; Uddin, N	1
Advani, R; Graves, EE; Hoppe, RT; Horning, S; Loo, BW; Quon, A; Rachakonda, LP; Su, Z; Tran, PT; Tseng, D	1
Bolacchi, F; Danieli, R; Della Gatta, F; Gaspari, E; Mancini, A; Orlacchio, A; Ragano Caracciolo, C; Schillaci, O; Simonetti, G	1
Bower, M; Cwynarski, K; Fields, P; Marcus, R; McNamara, C; Montoto, S; Okosun, J; Shaw, K; Virchis, A; Warbey, V	1
Bartlett, NL; Canellos, GP; Cheson, BD; Hall, NC; Johnson, JL; Jung, SH; Kostakoglu, L; LaCasce, AS; Schöder, H; Schwartz, LH; Straus, DJ	1
Botteri, E; Calabrese, L; Cocorocchio, E; Martinelli, G; Peccatori, F; Piperno, G; Preda, L; Travaini, L; Vanazzi, A	1
Poulou, LS; Thanos, L; Voulgarelis, M; Ziakas, PD	1
Escobar, H; Folkens, JU; Hoffmann, R; Kontny, U; Pohl, M; van Buiren, M; Wild, D; Yoshimi, A	1
Martis, N; Mounier, N	1
Mikhaeel, NG; Yeoh, KW	1
Elstrom, RL	1
Illés, A; Jóna, A; Lieber, A; Miltényi, Z; Páyer, E; Simon, Z; Szilasi, M	1
Cheng, G	1
Herzog, H	1
Cheng, G; Servaes, S; Zhuang, H	1
Avril, N; Barwick, T; El-Najjar, I; Montoto, S	1
Cantonetti, M; Caracciolo, CR; Chiaravalloti, A; Danieli, R; Di Pietro, B; Pagani, M; Schillaci, O; Simonetti, G; Tavolozza, M; Travascio, L	1
Alavi, A; Cheng, G	1
Hartridge-Lambert, SK; Lim, RC; Maragulia, JC; Portlock, CS; Schöder, H	1
Ardeshna, K; Goldstone, AH; Hough, R; Kayani, I; Linch, DC; Morris, EC; Peggs, KS; Thomson, KJ; Virchis, A	1
Agrawal, K; Bansal, D; Bhattacharya, A; Kashyap, R; Manohar, K; Marwaha, RK; Mittal, BR; Srinivasan, R; Trehan, A; Varma, N	1
Bukh, A; Bøgsted, M; Christiansen, I; d'Amore, F; de Nully Brown, P; El-Galaly, TC; Hjorthaug, K; Hutchings, M; Iyer, V; Johnsen, HE; Loft, A; Madsen, C; Mylam, KJ; Nielsen, AL; Specht, L	1
Ben-Arush, M; Ben-Barak, A; Ilivitzki, A; Israel, O; Radan, L	1
Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S	1
Akashi, K; Harada, Y; Kamezaki, K; Ohshima, K; Shimono, N	1
Delwail, V; Diviné, M; Guilhot, F; Perdrisot, R; Puyade, M; Tomowiak, C; Yacoub, M	1
Augeul-Meunier, K; Bodet-Milin, C; Dupas, B; Frampas, E; Gastinne, T; Le Gouill, S	1
Calcagni, ML; Carnassale, G; Giordano, A; Granone, P; Lococo, F; Petrone, G; Stefanelli, A; Treglia, G	1
Burger, IA; Goldman, DA; Gonen, M; Hricak, H; Kumar, A; Schöder, H; Vargas, HA; Zelenetz, AD	1
Bomanji, JB; Brock, C; Costa, DC; Dogan, A; Ell, PJ; Jankowska, P; Lee, SM; Syed, R	1
Albertini, P; Alinari, L; Baccarani, M; Chierichetti, F; Ferlin, G; Garraffa, G; Stefoni, V; Tani, M; Tura, S; Zinzani, PL; Zompatori, M	1
Coleman, M; Goldsmith, SJ; Kostakoglu, L; Kuji, I; Leonard, JP; Zoe, H	1
Lowe, VJ; Wiseman, GA	1
Hoffman, MA; Karayalcin, G; Manalili, EY; Mehrotra, B; Palestro, CJ; Rini, JN; Tomas, MB	1
Bender, LW; Francisco, R; Ojha, B; Scott, JW	1
Grahek, D; Kerrou, K; Landman-Parker, J; Leverger, G; McNamara, D; Montravers, F; Talbot, JN; Wioland, M; Younsi, N	1
Chen, T; Hayashi, K; Kaneko, K; Koga, H; Kuwabara, Y; Masuda, K; Nakagawa, M; Nakamura, K; Sasaki, M	1
De Winter, F; Dierckx, RA; Kolindou, A; Lambert, B; Noens, L; Van De Wiele, C; Van Den Bossche, B	1
Beuthien-Baumann, B; Bredow, J; Ehninger, G; Fischer, R; Kittner, T; Kropp, J; Naumann, R; Ockert, D	1
Beguin, YP; Jerusalem, GH	1
Berner, U; Diehl, M; Döbert, N; Grünwald, F; Menzel, C; Mitrou, P; Mose, S	1
Beguin, Y; Belhocine, T; Fassotte, MF; Fillet, G; Hustinx, R; Jerusalem, G; Rigo, P	1
Barrington, SF; Macdonald, EA; Mikhaeel, NG; O'Doherty, MJ; Schey, S	1
Borchmann, P; Diehl, V; Dietlein, M; Engert, A; Eschner, W; Fischer, T; Schicha, H; Schnell, R; Schomäcker, K; Staak, JO; Weihrauch, MR	1
Hoskin, PJ; O'Doherty, MJ	1
Mortelmans, L; Spaepen, K; Stroobants, S; Verhoef, G	1
Becherer, A; Jaeger, U; Kletter, K; Szabo, M	1
Bourguet, P	1
Eibl, M; Gallowitsch, HJ; Heinisch, M; Kresnik, E; Lind, P; Linkesch, W; Mikosch, P; Pipam, W; Unterweger, O; Zinke-Cerwenka, W	1
Alavi, A; Chiang, SB; Guan, L; Rebenstock, A; Zhuang, H	1
Bénard, F; Guay, C; Lépine, M; Verreault, J	1
Asaka, M; Baba, U; Fujisawa, F; Imamura, M; Miura, Y; Onodera, M; Ota, S; Tanaka, J; Toubai, T; Toyoshima, N	1
Ahmad, N; Keehn, CA; Seigne, J; Szabunio, M; Wade, M	1
Byrne, DW; Delbeke, D; Greer, JP; Hallahan, DE; Lavely, WC; Morgan, DS; Price, RR	1
Buchmann, I; Reske, SN; Wahl, A; Wandt, H	1
Berner, U; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Mitrou, P; Wördehoff, N	1
Bajzik, G; Csere, T; Esik, O; Lengyel, E; Lengyel, Z; Olajos, J; Sáfrány, G; Stefanits, K; Szakáll, S; Trón, L; Vönöczky, K	1
Futatsubashi, M; Kanno, T; Kobayashi, M; Nakamura, F; Okada, H; Ouchi, Y; Torizuka, T; Yoshikawa, E	1
Dannenberg, C; Dörffel, W; Hasenclever, D; Hirsch, W; Kluge, R; Körholz, D; Lotz, I; Lüders, H; Sabri, O; Wickmann, L	1
Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Görges, R; Jentzen, W; Müller, SP; Nowrousian, MR; Schütt, P	1
Chiusolo, P; Leone, G; Sica, S	1
van Spronsen, DJ; Veldhuis, GJ	1
Hudson, MM; Kaste, SC; Krasin, MJ	1
Beuthien-Baumann, B; Bredow, J; Ehninger, G; Hänel, A; Hänel, M; Kotzerke, J; Kropp, J; Kühnel, G; Laniado, M; Naumann, R; Reiss, A; Schulze, J	1
Alavi, A; Batlle, JC; Kumar, R; Potenta, S; Zhuang, H	1
Döbert, N; Grünwald, F; Hamscho, N; Kranert, WT; Menzel, C; Wördehoff, W	1
Bendandi, M; Boán, JF; García-Velloso, MJ; Panizo, C; Pérez-Salazar, M; Richter, J; Rocha, E; Rodríguez-Calvillo, M	1
Alavi, A; Downs, LH; Elstrom, RL; Schuster, SJ; Tsai, DE; Vergilio, JA	1
Goerres, GW; Hany, TF; Schaefer, NG; Seifert, B; Stumpe, KD; Taverna, C; von Schulthess, GK	1
Helmberger, T; Linke, R; Schroeder, M; Voltz, R	1
Burton, C; Ell, P; Linch, D	1
Eigtved, AI; Hutchings, M; Specht, L	1
Basu, S; Nair, N	2
Beuthien-Baumann, B; Naumann, R	1
Alavi, A; Kumar, R; Maillard, I; Schuster, SJ	1
Steinert, HC	1
Hart, D; Karayalcin, G; Leonidas, JC; Nichols, K; Núñez, R; Palestro, CJ; Rini, JN; Tomas, MB; Tronco, GG	1
Devenyi, K; Illes, A; Keresztes, K; Lengyel, Z; Miltenyi, Z; Vadasz, G	1
Ak, I; Gülbaş, Z	1
De Barsy, C; Depas, G; Dresse, MF; Fassotte, MF; Foidart, J; Hoyoux, C; Hustinx, R; Jerusalem, G; Paquet, N; Rigo, P	1
Alinari, L; Baccarani, M; Battista, G; Boschi, S; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Marengo, M; Monetti, N; Moretti, A; Nanni, C; Pettinato, C; Zinzani, P	1
Howard, SC; Hudson, MM; Kaste, SC; Kogos, PG; Krasin, MJ; McCarville, EB	1
Franzius, C; Heindel, W; Hermann, S; Hunold, A; Jürgens, H; Pixberg, M; Schober, O; Wormanns, D	1
Avivi, I; Bomanji, JB; Ell, PJ; Goldstone, AH; Hart, DP; Linch, DC; Mackinnon, S; Morris, EC; Peggs, KS; Thomson, KJ	1
Alavi, A; Alinari, L; Battista, G; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Monetti, N; Nanni, C; Pourdehnad, M; Rubello, D; Stefoni, V; Tani, M; Zinzani, P	1
Branquet, D; de Revel, T; Doghmi, K; El Ouennass, M; Fagot, T; Foissaud, V; Forel, A; Malfuson, JV; Nedellec, G; Samson, T	1
Fields, PA; Hutchings, M; Mikhaeel, NG; Nunan, T; Timothy, AR	1
Altehoefer, C; Finke, J; Herkel, C; Moser, E; Reinhardt, MJ	1
Berthelsen, AK; Boesen, AM; Buhl, T; Buus, S; D'Amore, F; Hansen, M; Hutchings, M; Jurlander, J; Keiding, S; Loft, A; Pedersen, LM; Specht, L	1
Apter, S; Ben-Bassat, I; Even-Sapir, E; Metser, U; Nagler, A; Naparstek, E; Perry, C; Polliack, A; Raanani, P; Shasha, Y	1
Fink-Bennett, D; Gaskill, M; Hill, J; Margolis, JH; Nagle, C; Parling-Lynch, KJ; Qing, F; Thie, J; Wong, CY; Zakalik, D	1
Alterini, R; Bernardi, F; Bosi, A; Carpaneto, A; Carrai, V; Castagnoli, A; Dini, C; Matteini, M; Nassi, L; Pieroni, C; Rigacci, L	1
Hany, TF; Strobel, K; Thuerl, CM	1
de Klerk, JM; Geerts, MC; Kramer, MH; Quarles van Ufford, HM; van Waes, PF	1
Advani, R; Ai, WZ; Horning, SJ	1
Belohlavek, O; Chanova, M; Cumlivska, E; Drahokoupilova, E; Hladikova, M; Kabickova, E; Kodet, R; Nekolna, M; Sumerauer, D	1
Biggi, A; Bosi, A; Capodanno, I; Castagnoli, A; Gallamini, A; Gregianin, M; Iannitto, E; Levis, A; Luminari, S; Merli, F; Nassi, L; Pelosi, E; Rigacci, L; Sancetta, R; Stelitano, C; Tavera, S; Torchio, P; Trentin, L; Versari, A; Vitolo, U	1
Alavi, A; Hernandez-Pampaloni, M; Takalkar, A; Yu, JQ; Zhuang, H	1
Bomanji, JB; Kottaridis, PD; Mackinnon, S; Stewart, WA	1
Altehoefer, C; Bucerius, J; Finke, J; Herkel, C; Joe, AY; Moser, E; Reinhardt, MJ	1
Hansen, M; Hutchings, M; Loft, A; Ralfkiaer, E; Specht, L	1
Alavi, A; Andreadis, C; Berkowitz, A; Chong, EA; Downs, LH; Elstrom, R; Glatstein, E; Loren, AW; Luger, SM; Nasta, S; Porter, DL; Schuster, SJ; Siegel, DL; Stadtmauer, EA; Svoboda, J; Tsai, D	1
Delbeke, D; Frangoul, HA; Kuttesch, JF; Martin, W; Rhodes, MM; Shankar, S; Whitlock, JA	1
De Winter, O; Goethals, I; Noens, L; Smeets, P	1
Bodet-Milin, C; Carlier, T; Chatal, JF; Couturier, O; Harousseau, JL; Oudoux, A; Querellou, S; Valette, F	1
Jhanwar, YS; Straus, DJ	1
Ganju, V; Grigg, A	1
Amthauer, H; Denecke, T; Furth, C; Henze, G; Lemke, AJ; Misch, D; Plotkin, M; Ruf, J; Steffen, I; Stöver, B; Voelker, T; Vondran, F	1
Arrossi, AV; Kirsch, J; Neumann, DR; Wu, G; Yoon, JK	1
Altavilla, G; Arrigo, C; Cavallari, V; Naro, C; Navarra, G; Pitini, V	1
Coleman, M; Kostakoglu, L	1
Bjurberg, M; Brun, E; Gustavsson, A; Ohlsson, T	1
Pruim, J; Schot, BW; Sluiter, WJ; Vaalburg, W; van Imhoff, GW; Vellenga, E; Zijlstra, JM	1
Coya, J; Gómez-León, N; Hernández-Maraver, D; Madero, R; Martín-Curto, L; Pinilla, I; Rodríguez-Vigil, B	1
Coya, J; Gomez-Leon, N; Hernandez-Maraver, D; Hernandez-Navarro, F; Madero, R; Martin-Curto, LM; Pinilla, I; Rodriguez-Vigil, B	1
Atasever, T; Chandramouly, A; Christos, P; Coleman, M; Furman, RR; Goldsmith, SJ; Kostakoglu, L; Kothari, P; Leonard, JP; Verma, S	1
Kelly, KM; Levine, JM; Weiner, M	1
Canessa G, J; González E, P; Humeres A, P; Jofré M, MJ; Massardo V, T; Sierralta G, P	1
Rademaker, J	1
Coronado Poggio, M; Couto Caro, RM; Frutos Esteban, L; Lillo García, ME; Marín Ferrer, MD; Martín Curto, LM	1
Groshar, D; Gurion, R; Raanani, P; Schindel, A; Shpilberg, O	1
Cheson, BD; Coiffier, B; Connors, JM; Diehl, V; Dreyling, M; Federico, M; Fisher, RI; Gascoyne, RD; Hagenbeek, A; Hoppe, RT; Horning, SJ; Juweid, ME; Lister, TA; Pfistner, B; Rosen, ST; Specht, L; Stroobants, S; Tobinai, K; Vose, JM; Zucca, E	1
Juengling, FD; Krause, T; Vock, J; Wissmeyer, M	1
Berthelsen, AK; Hansen, M; Hutchings, M; Loft, A; Specht, L	1
Carlier, T; Chatal, JF; Couturier, O; Dupas, B; Oudoux, A; Querellou, S; Valette, F	1
Arai, Y; Hamashima, C; Kim, EE; Maeda, T; Moriyama, N; Sugimura, K; Tateishi, U; Terauchi, T	1
Bui, C; Frey, KA; Hutchinson, RJ; Mody, RJ; Shulkin, BL	1
Bonardel, G; Brisse, H; Edeline, V; Foehrenbach, H; Gaillard, JF; Maszelin, P; Michon, J; Neuenschwander, S; Pacquement, H	1
Anderlini, P; Ayers, G; Fayad, L; Hagemeister, F; Hosing, C; Jabbour, E; Khouri, I; Kwak, L; Nunez, R; Pro, B; Younes, A	1
Buccheri, V; Cerci, JJ; Chaves, AA; Meneghetti, JC; Pracchia, LF; Soares Junior, J	1
Hany, TF; Kurrer, M; Schaefer, NG; Strobel, K; Taverna, C; Wastl, C	1
Endo, K; Handa, H; Hasegawa, M; Kojima, M; Matsushima, T; Murakami, H; Oriuchi, N; Saitoh, T; Tsukamoto, N; Yokohama, A	1
Specht, L	2
Biggi, A; D'Amore, F; Di Raimondo, F; Gallamini, A; Hansen, M; Hutchings, M; Iannitto, E; Levis, A; Loft, A; Luminari, S; Merli, F; Patti, C; Pierri, I; Rigacci, L; Sancetta, R; Specht, L; Stelitano, C; Trentin, L; Vitolo, U; Viviani, S	1
Galanski, M; Gratz, KF; Rosenthal, H; von Falck, C	1
Alvarez, I; Biggi, A; Bosi, A; Castagnoli, A; Chisesi, T; Gallamini, A; Gregianin, M; Levis, A; Merli, F; Nassi, L; Pelosi, E; Pregno, P; Rigacci, L; Salvi, F; Sancetta, R; Versari, A; Vitolo, U	1
Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G	1
Even-Sapir, E; Herishanu, Y; Lerman, H; Lievshitz, G; Metser, U; Perry, C	1
Bayla, A; Bonniaud, G; Ferreira, I; Ghalibafian, M; Girinsky, T; Lumbroso, J; Magne, N	1
Hicks, RJ; MacManus, MP; Seymour, JF	1
Yahalom, J	1
De Renzo, A; Nicolai, E; Pacelli, R; Pane, F; Picardi, M; Rotoli, B; Salvatore, M	1
Galanski, M; Knapp, WH; Laenger, F; Lotz, J; Rosenthal, H; von Falck, C	1
Israel, DA; Sheehy, N	1
Capello, D; Capparella, V; Cianciulli, M; Emili, R; Falchi, L; Liberati, AM; Liberati, F; Pace, R; Palumbo, B; Rauco, A	1
Bomanji, J; Buchler, T; Lee, SM	1
Altamirano, J; Calvo, PS; Chalapud Revelo, JR; de la Garza Salazar, J; Esparza, JR; Estrada, G; Vera, SR	1
Ciceri, F; Fallanca, F; Fazio, F; Gianolli, L; Giovacchini, G; Ponzoni, M	1
Hotta, T; Nagai, H; Nihashi, T; Terasawa, T	1
Bomanji, J; Buchler, T; Edwards, SG; Lee, SM; Ramsay, A	1
Comans, EF; ten Hove, CH; van Elburg, RM; Zijlstra-Baalbergen, JM	1
Ansquer, C; de Guibert, S; Devillers, A; Garin, E; Gastinne, T; Hervouët, T; Kraeber-Bodéré, F; Lamy, T; Le Gouill, S; Moreau, A	1
Hampson, FA; Shaw, AS	1
Al-Nahhas, A; Banti, E; Paolini, R; Ramazzina, E; Rampin, L; Rodella, E; Rubello, D	1
Bisi, G; Chiappella, A; Deandreis, D; Pelosi, E; Penna, D; Skanjeti, A; Vitolo, U	1
Subbiah, V	1
Kasamon, YL; Wahl, RL	1
Karianakis, G; Poulou, LS; Ziakas, PD	1
Friedmann, AM; Weinstein, HJ	1
Avigdor, A; Gallamini, A; Hutchings, M; Polliack, A	1
Bisi, G; Chiappella, A; Deandreis, D; Gallo, E; Limerutti, G; Mancini, M; Pelosi, E; Penna, D; Pregno, P; Vitolo, U	1
Connerotte, T; de Meeûs, Y; Ferrant, A; Hermans, C; Lonneux, M; Van Den Neste, E; Vekemans, MC	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Lorenz, WJ; Maier-Borst, W; Strauss, LG; van Kaick, G	1
Arimizu, N; Imaseki, K; Itami, J; Okada, J; Oonishi, H; Uno, K; Yoshikawa, K	1
Bergman, J; Knuuti, MJ; Lindholm, P; Minn, H; Nuutila, P; Ruotsalainen, U; Teräs, M	1
Francis, IR; Kaminski, MS; Newman, JS; Wahl, RL	1
Bares, R; Büll, U; Dempke, W; Galonska, P; Handt, S; Osieka, R	1
Aberle, DR; Dahlbom, M; Glaspy, JA; Hawkins, RA; Hoh, CK; Phelps, ME; Razavi, MK; Rege, SD	1
Golding, R; Hoekstra, OS; Huijgens, PC; Ossenkoppele, GJ; Teule, GJ; van Lingen, A; Visser, GW	1
Dahlbom, M; Glaspy, J; Hawkin, RA; Hoh, CK; Kunkel, L; Lee, SJ; Maddahi, J; Phelps, ME; Rosen, P	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Hegenbart, U; Irngartinger, G; Oberdorfer, F; Strauss, LG; van Kaick, G	1
Bangerter, M; Diederichs, CG; Guhlmann, A; Herrmann, F; Kolokythas, O; Kotzerke, J; Merkle, E; Moog, F; Reske, SN	1
Beyer, W; Bumann, D; Clausen, M; de Wit, M; Herbst, K; Hossfeld, DK	1
Babchyck, B; Belakhlef, A; Kochen, J; Weinblatt, ME; Zanzi, I	1
Büll, U; Cremerius, U; Fabry, U; Günther, R; Hellwig, D; Neuerburg, J; Osieka, R; Thill, R; Wagenknecht, G	1
Bangerter, M; Diederichs, CG; Frickhofen, N; Guhlmann, A; Merkle, E; Moog, F; Reske, SN	1
Bangerter, M; Frickhofen, N; Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN	1
Celsing, F; Ingvar, M; Jacobsson, H; Larsson, SA; Stone-Elander, S	1
Beese, M; Beyer, W; Bücheler, E; Bumann, D; Clausen, M; de Wit, M; Lübeck, M	1
Buck, A; Glanzmann, C; Steinert, HC; Stumpe, KD; Urbinelli, M; von Schulthess, GK	1
Biersack, HJ; Grünwald, F; Palmedo, H; Ruhlmann, J; Willkomm, P	1
Bangerter, M; Bergmann, L; Buchmann, I; Elsner, K; Frickhofen, N; Griesshammer, M; Hafner, M; Kotzerke, J; Moog, F; Reske, SN	1
Buell, U; Cremerius, U; Fabry, U; Neuerburg, J; Osieka, R; Zimny, M	1
Frickhofen, N; Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN	1
Fassotte, MF; Fillet, G; Jerusalem, G; Najjar, F; Paulus, P; Rigo, P; Warland, V	1
Büll, U; Cremerius, U; Fabry, U; Kröll, U; Neuerburg, J; Osieka, R; Zimny, M	1
Beguin, Y; Fassotte, MF; Fillet, G; Jerusalem, G; Najjar, F; Paulus, P; Rigo, P	2
Bergman, J; Haaparanta, M; Knuuti, J; Laine, H; Minn, H; Nuutinen, J; Ruotasalainen, U	1
Adams, S; Baican, B; Baum, RP; Chow, KU; Hertel, A; Hoelzer, D; Hör, G; Knupp, B; Mitrou, PS; Wiedmann, E	1
Hain, SF; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR	1
Buchmann, I; Moog, F; Reske, SN; Schirrmeister, H	1
Gibson, P; Hoskin, P; Lowe, J; McMillan, A; Shah, N; wong, WL	1
Hwang, K; Kim, H; Kim, HC; Kim, S; Pai, M; Park, CH; Yoon, S	1
Fridrik, M; Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G	1
Cabrera Villegas, A; Cánovas Fernández, A; Martín Urreta, JC	1
Agress, H	1
Hain, SF; Mikhaeel, G; O'Doherty, MJ; Partridge, S; Rankin, S; Timothy, A	1
Bihl, H; Fischer, J; Hueltenschmidt, B; Lang, O; Maul, FD; Mergenthaler, HG; Sautter-Bihl, ML	1
Bohuslavizki, KH; Buchert, R; Bumann, D; Clausen, M; de Wit, M; Hossfeld, DK	1
Bihl, H; Hültenschmidt, B; Lang, O; Sautter-Bihl, ML	1
Kuwert, T	1
Alavi, A; Liu, Y; Pourdehnad, M; Sinha, P; Yamamoto, AJ; Zhuang, H	1
Bares, R; Büll, U; Cremerius, U; Fabry, U; Neuerburg, J; Osieka, R; Zimny, M	1
Bar-Shalom, R; Goldsmith, SJ; Mor, M; Yefremov, N	1
Avril, N; Link, T; Peschel, C; Sandherr, M; Stock, K; von Bubnoff, N; von Schilling, C	1
Ariannejad, M; Czernin, J; Meta, J; Phelps, ME; Rao, J; Sayre, J; Schöder, H; Valk, PE; Yap, C	1
Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J	1
Balzarini, J; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Vandenberghe, P; Verhoef, G	1
Gundlapalli, S; Mountz, JM; Ojha, B	1
Mortelmans, L; Spaepen, K	1
Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Franklin, J; Krug, B; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Textoris, F; Weihrauch, MR; Wolf, J	1
Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M	1
Beuthien-Baumann, B; Bredow, J; Ehninger, G; Franke, WG; Kittner, T; Kropp, J; Naumann, R; Vaic, A	1
Fisher, R; Hicks, RJ; Januszewicz, H; MacManus, MP; Prince, M; Ryan, G; Seymour, JF; Ware, R; Wirth, A; Wolf, M	1
Kaplan, LD	1
Hoskin, PJ	1
Coleman, M; Goldsmith, SJ; Kostakoglu, L; Kuji, I; Leonard, JP; Vallabhajosula, S	1
Alavi, A; Alnafisi, N; Hickeson, M; Kim, W; Yun, M	1
Carpaneto, A; Carrai, V; Castagnoli, A; Matteini, M; Rigacci, L; Vaggelli, L	1
Beggs, AD; Hain, SF	1
Higuchi, T	1
Deák, B; Esik, O; Lengyel, Z; Molnár, Z; Rosta, A; Schneider, T; Székely, J; Trón, L; Várady, E	1
Green, MV; Herscheid, KD; Hoekstra, OS; Huijgens, PC; Huitink, H; Martens, HJ; Ossenkoppele, GJ; Teule, GJ; van Lingen, A; Visser, FC	1
Bischoff, H; Knopp, MV; Oberdorfer, F; van Kaick, G	1
Arimizu, N; Imaseki, K; Itami, J; Itami, M; Kuyama, J; Mikata, A; Okada, J; Uno, K; Yoshikawa, K	1
Arimizu, N; Imazeki, K; Itami, J; Kuyama, J; Maruno, H; Minoshima, S; Okada, J; Uno, K; Yoshikawa, K	1

Reviews

89 review(s) available for fluorodeoxyglucose f18 and Hodgkin Disease

Article	Year
Current Role of Functional Imaging in the Management of Lymphoma. Current oncology reports, 2021, 11-04, Volume: 23, Issue:12 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Practice Guidelines as Topic	2021
Modern PET-Guided Radiotherapy Planning and Treatment for Malignant Lymphoma. Seminars in nuclear medicine, 2023, Volume: 53, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis	2023
Molecular Imaging of Lymphoma: Future Directions and Perspectives. Seminars in nuclear medicine, 2023, Volume: 53, Issue:3 Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
PET/CT in Hodgkin Lymphoma: An Update. Seminars in nuclear medicine, 2023, Volume: 53, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed	2023
Interim FDG-PET/CT for Response Assessment of Lymphoma. Seminars in nuclear medicine, 2023, Volume: 53, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis	2023
Current Evidence on PET Response Assessment to Immunotherapy in Lymphomas. PET clinics, 2020, Volume: 15, Issue:1 Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Epidemiologic Methods; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunotherapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome	2020
Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma. Medicina clinica, 2020, 01-24, Volume: 154, Issue:2 Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Examination; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Liver; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; Young Adult	2020
PET Guided Therapy for Early Stage Hodgkin Lymphoma: Are We Positive About a Negative Interim Scan? International journal of radiation oncology, biology, physics, 2020, 05-01, Volume: 107, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2020
Update on Hodgkin lymphoma from a radiologist's perspective. Clinical imaging, 2020, Volume: 65 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiologists; Radiopharmaceuticals; Tomography, X-Ray Computed	2020
Liver involvement in pediatric Hodgkin lymphoma: A systematic review by an international collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL). Pediatric blood & cancer, 2020, Volume: 67, Issue:8 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Liver; Liver Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Young Adult	2020
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group. Pediatric blood & cancer, 2020, Volume: 67, Issue:9 Topics: Adenoids; Expert Testimony; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Oropharynx; Palate, Soft; Palatine Tonsil; Positron-Emission Tomography; Tongue	2020
Diagnostic performance of F-18 FDG PET/CT in the detection of bone marrow involvement in paediatric hodgkin lymphoma: A meta-analysis. Leukemia research, 2021, Volume: 102 Topics: Bone Marrow; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:Suppl 1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Treatment Outcome	2017
Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma. Seminars in nuclear medicine, 2017, Volume: 47, Issue:3 Topics: Child; Clinical Trials as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Treatment Outcome	2017
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Precision Medicine	2017
An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma. Seminars in oncology, 2017, Volume: 44, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2017
FDG-PET/CT in the management of lymphomas: current status and future directions. Journal of internal medicine, 2018, Volume: 284, Issue:4 Topics: Biopsy; Bone Marrow; Cell Transformation, Neoplastic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome; Tumor Burden	2018
Role of FDG PET-CT in the treatment management of Hodgkin lymphoma. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2018, Volume: 22, Issue:5 Topics: Antineoplastic Agents; Clinical Decision-Making; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Irradiation; Neoplasm Staging; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Image-Guided	2018
Multimodality imaging using PET/CT ( Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2018, Volume: 22, Issue:5 Topics: Documentation; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Irradiation; Occupational Exposure; Patient Positioning; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiopharmaceuticals; Radiotherapy, Image-Guided	2018
Response-Adapted Treatment Strategies in Hodgkin Lymphoma Using PET Imaging. PET clinics, 2019, Volume: 14, Issue:3 Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome	2019
The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood. European journal of pediatrics, 2013, Volume: 172, Issue:6 Topics: Chemoradiotherapy; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2013
Combination chemoradiotherapy in early Hodgkin lymphoma. Hematology/oncology clinics of North America, 2014, Volume: 28, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy; Treatment Outcome	2014
FDG-PET response-adapted therapy: is 18F-fluorodeoxyglucose positron emission tomography a safe predictor for a change of therapy? Hematology/oncology clinics of North America, 2014, Volume: 28, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome	2014
Relapsed/refractory Hodgkin lymphoma: what is the best salvage therapy and do we need RIC-alloSCT? Hematology/oncology clinics of North America, 2014, Volume: 28, Issue:1 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2014
Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:5 Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed	2014
Role of PET in lymphoma. Current treatment options in oncology, 2014, Volume: 15, Issue:2 Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Conformal; Sensitivity and Specificity; Treatment Outcome	2014
FDG-PET imaging for Hodgkin lymphoma: current use and future applications. Clinical advances in hematology & oncology : H&O, 2014, Volume: 12, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Reproducibility of Results	2014
The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Blood, 2014, Nov-27, Volume: 124, Issue:23 Topics: Clinical Trials, Phase II as Topic; Early Diagnosis; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results	2014
Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach? Blood, 2015, Jan-01, Volume: 125, Issue:1 Topics: Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Decision Making; Drug Therapy; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Hodgkin Disease; Humans; Immunophenotyping; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Mediastinum; Positron-Emission Tomography; Recurrence; Rituximab; Treatment Outcome	2015
How I treat advanced classical Hodgkin lymphoma. Blood, 2015, Mar-12, Volume: 125, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2015
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma. The Cochrane database of systematic reviews, 2015, Jan-09, Volume: 1 Topics: Antineoplastic Agents; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Selection Bias	2015
Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma. Blood, 2015, Mar-12, Volume: 125, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Risk Factors; Young Adult	2015
The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Hematology. American Society of Hematology. Education Program, 2014, Dec-05, Volume: 2014, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Tomography, X-Ray Computed	2014
Risk- and response-adapted strategies for the management of Hodgkin lymphoma. Chinese clinical oncology, 2015, Volume: 4, Issue:1 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome	2015
Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis. British journal of haematology, 2015, Volume: 170, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; MEDLINE; Models, Biological; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals	2015
Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Blood reviews, 2015, Volume: 29, Issue:6 Topics: Biological Transport; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2015
Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging. Current treatment options in oncology, 2015, Volume: 16, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed	2015
Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy. Annals of hematology, 2016, Volume: 95, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies	2016
The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma: a systematic review and meta-analysis. Nuclear medicine communications, 2016, Volume: 37, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Stem Cell Transplantation	2016
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis. Annals of hematology, 2016, Volume: 95, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Disease Progression; Drug Resistance, Neoplasm; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Transplantation, Autologous; Treatment Outcome	2016
Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma. European journal of haematology, 2016, Volume: 97, Issue:6 Topics: Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Treatment Outcome	2016
[New therapy outlooks in Hodgkin lymphoma]. Bulletin du cancer, 2017, Volume: 104, Issue:2 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Brentuximab Vedotin; Cell Cycle Checkpoints; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunoconjugates; Positron Emission Tomography Computed Tomography; Prognosis; Protein Kinase Inhibitors; Radiopharmaceuticals; Recurrence; Reed-Sternberg Cells; Salvage Therapy; Tumor Microenvironment	2017
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma. Oncology (Williston Park, N.Y.), 2017, 01-15, Volume: 31, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine	2017
Modern treatment of Hodgkin lymphoma. Current opinion in hematology, 2008, Volume: 15, Issue:4 Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis	2008
Role of PET/CT scanning in initial and post-treatment assessment of Hodgkin disease. Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:6 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed	2008
PET scanning and prognosis in Hodgkin's lymphoma. Current opinion in oncology, 2008, Volume: 20, Issue:5 Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Apr-10, Volume: 27, Issue:11 Topics: Adolescent; Adult; Child; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals	2009
Measuring response with FDG-PET: methodological aspects. The oncologist, 2009, Volume: 14, Issue:4 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms	2009
Standard therapy of advanced Hodgkin lymphoma. Hematology. American Society of Hematology. Education Program, 2009 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2009
An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Journal of the National Comprehensive Cancer Network : JNCCN, 2010, Volume: 8, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome	2010
The role of PET in Hodgkin's lymphoma and its impact on radiation oncology. Expert review of anticancer therapy, 2010, Volume: 10, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clinical Trials as Topic; Disease-Free Survival; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2010
PET imaging in lymphoma. Expert review of hematology, 2009, Volume: 2, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2009
FDG-PET/CT in lymphoma. Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed	2011
Personalized treatment of lymphoma: promise and reality. Seminars in oncology, 2011, Volume: 38, Issue:2 Topics: Cancer Vaccines; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Precision Medicine	2011
Magnetic resonance imaging of malignant lymphoma. Expert review of hematology, 2011, Volume: 4, Issue:2 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging	2011
[Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma]. Klinische Padiatrie, 2011, Volume: 223, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Evidence-Based Medicine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Treatment Outcome	2011
The Gordian knot of interim 18-fluorodeoxyglucose positron emission tomography for Hodgkin lymphoma: a meta-analysis and commentary on published studies. Leukemia & lymphoma, 2012, Volume: 53, Issue:11 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals	2012
Hodgkin lymphoma in patients with HIV infection: a review. Current hematologic malignancy reports, 2012, Volume: 7, Issue:3 Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coinfection; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Positron-Emission Tomography; Prognosis	2012
Are we ready for positron emission tomography/computed tomography-based target volume definition in lymphoma radiation therapy? International journal of radiation oncology, biology, physics, 2013, Jan-01, Volume: 85, Issue:1 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden	2013
Value of 18F-FDG PET versus iliac biopsy in the initial evaluation of bone marrow infiltration in the case of Hodgkin's disease: a meta-analysis. Nuclear medicine communications, 2013, Volume: 34, Issue:1 Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Positron-Emission Tomography	2013
How does PET/CT help in selecting therapy for patients with Hodgkin lymphoma? Hematology. American Society of Hematology. Education Program, 2012, Volume: 2012 Topics: Decision Support Systems, Clinical; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Medical Oncology; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Risk; Tomography, X-Ray Computed; Treatment Outcome	2012
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects]. Nuklearmedizin. Nuclear medicine, 2003, Volume: 42, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multicenter Studies as Topic; Predictive Value of Tests; Radioimmunotherapy; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Positron emission tomography in the management of lymphomas: a summary. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30 Suppl 1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30 Suppl 1 Topics: Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Predictive Value of Tests; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Prognostic value of FDG-PET in malignant lymphoma. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2003, Volume: 47, Issue:1 Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Indium Radioisotopes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Thallium; Tomography, Emission-Computed; Treatment Outcome	2003
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma]. Bulletin du cancer, 2003, Volume: 90 Spec No Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2003
New developments in staging and follow-up of patients with Hodgkin's lymphoma. The Netherlands journal of medicine, 2003, Volume: 61, Issue:9 Topics: Aged; Antineoplastic Agents; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Staging; Prognosis; Survival Rate; Tomography, Emission-Computed	2003
PET imaging in pediatric Hodgkin's lymphoma. Pediatric radiology, 2004, Volume: 34, Issue:3 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Protocols; Child; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
The role of PET imaging in lymphoma. British journal of haematology, 2004, Volume: 126, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Tomography, Emission-Computed; Treatment Outcome	2004
FDG-PET in the clinical management of Hodgkin lymphoma. Critical reviews in oncology/hematology, 2004, Volume: 52, Issue:1 Topics: Drug Monitoring; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy, Adjuvant	2004
Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiologic clinics of North America, 2004, Volume: 42, Issue:6 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting	2004
18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Pediatric radiology, 2005, Volume: 35, Issue:2 Topics: Adipose Tissue; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Germinal Center; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Infections; Radiopharmaceuticals; Thymus Gland; Tomography, Emission-Computed	2005
How much intravenous contrast is needed in FDG-PET/CT? Nuklearmedizin. Nuclear medicine, 2005, Volume: 44 Suppl 1 Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2005
Management of advanced stage Hodgkin lymphoma. Journal of the National Comprehensive Cancer Network : JNCCN, 2006, Volume: 4, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy	2006
The role of PET in lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:8 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Medical Oncology; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2006
[Role of 18Fluorine-deoxyglucose (FDG) positron emission tomography in the management of lymphomas]. Revista medica de Chile, 2006, Volume: 134, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity	2006
2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Seminars in radiation oncology, 2007, Volume: 17, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome	2007
Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Radiologic clinics of North America, 2007, Volume: 45, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2007
Overview of early response assessment in lymphoma with FDG-PET. Cancer imaging : the official publication of the International Cancer Imaging Society, 2007, Volume: 7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Disease Management; Disease Progression; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals	2007
Is [(18)F]fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment? Hematology/oncology clinics of North America, 2007, Volume: 21, Issue:5 Topics: Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Remission Induction	2007
18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:1 Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2008
18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2008
Response assessment in lymphoma. Clinical radiology, 2008, Volume: 63, Issue:2 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma. Current opinion in oncology, 2008, Volume: 20, Issue:2 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Treatment Outcome	2008
FDG PET scan strategies and long-term outcomes after first-line therapy in Hodgkin's disease. European journal of radiology, 2009, Volume: 70, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Longitudinal Studies; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome	2009
Early interim PET scan in Hodgkin lymphoma: where do we stand? Leukemia & lymphoma, 2008, Volume: 49, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2008
The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. Seminars in nuclear medicine, 2001, Volume: 31, Issue:3 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:3 Topics: Fluorine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2001
[Positron emission tomography of the thorax. The current clinical status]. Der Radiologe, 1992, Volume: 32, Issue:6 Topics: Carcinoma, Bronchogenic; Deoxyglucose; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Tomography, Emission-Computed	1992

Trials

50 trial(s) available for fluorodeoxyglucose f18 and Hodgkin Disease

Article	Year
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial. Hematological oncology, 2023, Volume: 41, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results; Treatment Outcome; Vinblastine	2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial. JAMA oncology, 2023, 05-01, Volume: 9, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ifosfamide; Male; Positron Emission Tomography Computed Tomography; Salvage Therapy	2023
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study. Annals of hematology, 2020, Volume: 99, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autografts; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prospective Studies; Stem Cell Transplantation; Survival Rate; Vinblastine	2020
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial. Pediatric blood & cancer, 2021, Volume: 68, Issue:4 Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2021
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial. Annals of hematology, 2021, Volume: 100, Issue:6 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Young Adult	2021
ABVD Without Radiation for Newly Diagnosed Pediatric and Young Adult Patients With Hodgkin Lymphoma: A Single Center Retrospective Analysis of 28 Consecutive Patients. Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Vinblastine	2018
Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma. BMC cancer, 2018, May-03, Volume: 18, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Induction Chemotherapy; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Tumor Burden	2018
Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including European radiology, 2019, Volume: 29, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reference Standards; Whole Body Imaging; Young Adult	2019
Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031. Pediatric radiology, 2018, Volume: 48, Issue:12 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Pleural Effusion; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors	2018
The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II Study. Acta medica Okayama, 2018, Volume: 72, Issue:4 Topics: Child; Clinical Trials, Phase II as Topic; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multicenter Studies as Topic; Positron-Emission Tomography; Retrospective Studies	2018
Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures. Radiology, 2014, Volume: 272, Issue:1 Topics: Adolescent; Adult; Aged; Algorithms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler	2014
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jun-10, Volume: 32, Issue:17 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Vincristine; Young Adult	2014
Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold. Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast; Breath Holding; Female; Fluorodeoxyglucose F18; Heart; Hodgkin Disease; Humans; Inhalation; Lung; Male; Middle Aged; Multimodal Imaging; Organs at Risk; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals; Radiotherapy, Image-Guided; Tomography, X-Ray Computed; Young Adult	2015
Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients. International journal of radiation oncology, biology, physics, 2014, Aug-01, Volume: 89, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Diaphragm; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Vinblastine; Young Adult	2014
Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy. Klinische Padiatrie, 2014, Volume: 226, Issue:6-7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiation Injuries; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Vinblastine; Young Adult	2014
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group. International journal of radiation oncology, biology, physics, 2015, May-01, Volume: 92, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Germany; Hodgkin Disease; Humans; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Recurrence; Vincristine	2015
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 06-10, Volume: 34, Issue:17 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Vinblastine; Vincristine; Young Adult	2016
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial. Leukemia & lymphoma, 2017, Volume: 58, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; HIV Seropositivity; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome; Vinblastine	2017
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma. Blood, 2008, Nov-15, Volume: 112, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Radiography; Radiopharmaceuticals; Risk Factors; Survival Rate; Vincristine	2008
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine; Young Adult	2009
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma. British journal of haematology, 2009, Volume: 147, Issue:1 Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Hydroxamic Acids; Indoles; Male; Middle Aged; Panobinostat; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2009
18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Vinblastine; Young Adult	2010
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. Blood, 2012, Feb-16, Volume: 119, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calibration; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Standard of Care; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult	2012
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone? Leukemia & lymphoma, 2012, Volume: 53, Issue:11 Topics: Adult; Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma? Nuclear medicine communications, 2013, Volume: 34, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Brain; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Vinblastine	2013
F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clinical nuclear medicine, 2002, Volume: 27, Issue:8 Topics: Adolescent; Adult; Aged; Child; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Splenic Neoplasms; Tomography, Emission-Computed; Whole-Body Counting	2002
Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma. Annals of nuclear medicine, 2002, Volume: 16, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Citrates; Decision Making; Female; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting	2002
18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients. Nuclear medicine communications, 2002, Volume: 23, Issue:11 Topics: Adolescent; Adult; Citrates; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Drug Monitoring; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome	2004
FDG-PET/CT in re-staging of patients with lymphoma. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:3 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome	2004
Positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual Hodgkin's disease mediastinal masses. Leukemia & lymphoma, 2004, Volume: 45, Issue:9 Topics: False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Survival Rate; Treatment Outcome	2004
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Survival Analysis	2005
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood, 2006, Jan-01, Volume: 107, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Regression Analysis; Survival Analysis; Treatment Failure	2006
Glucose-normalized standardized uptake value from (18)F-FDG PET in classifying lymphomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:10 Topics: Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index	2005
18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results. Oncology reports, 2005, Volume: 14, Issue:5 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2005
Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:9 Topics: Adolescent; Child; Child, Preschool; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Tomography, X-Ray Computed	2006
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica, 2006, Volume: 91, Issue:4 Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Treatment Outcome	2006
Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake. Hematological oncology, 2006, Volume: 24, Issue:3 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity	2006
Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:8 Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2006
Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood, 2007, Jan-15, Volume: 109, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Transplantation, Autologous; Treatment Outcome	2007
Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. European journal of haematology, 2007, Volume: 78, Issue:3 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2007
Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi. Annals of hematology, 2007, Volume: 86, Issue:12 Topics: Adolescent; Adult; Aged; Bone Marrow; Disease Management; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Italy; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Leukemia & lymphoma, 2007, Volume: 48, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2007
The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: preliminary results of a prospective study. Nuclear medicine review. Central & Eastern Europe, 2007, Volume: 10, Issue:2 Topics: Adolescent; Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome	2007
Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8 Suppl 1 Topics: Adult; Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Whole-Body Counting	1997
Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. European journal of nuclear medicine, 1998, Volume: 25, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1998
Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease. Leukemia & lymphoma, 1999, Volume: 34, Issue:5-6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	1999
18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Child; Child, Preschool; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:8 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, Emission-Computed; Whole-Body Counting	2001
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer, 2002, Feb-15, Volume: 94, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002

Other Studies

512 other study(ies) available for fluorodeoxyglucose f18 and Hodgkin Disease

Article	Year
Cholesterol Granuloma: Unusual Pitfall for Hodgkin Lymphoma Evaluation With 18F-FDG PET/CT. Clinical nuclear medicine, 2021, Oct-01, Volume: 46, Issue:10 Topics: Cholesterol; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Synchronous Recurrence of Metachronous Lung Cancer and Hodgkin Lymphoma Within an Axillary Lymph Node Isolated on 18F-FDG PET/CT. Clinical nuclear medicine, 2022, Mar-01, Volume: 47, Issue:3 Topics: Adult; Aged, 80 and over; Axilla; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Lung Neoplasms; Lymph Nodes; Male; Melanoma; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thorax	2022
Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach. Medicina (Kaunas, Lithuania), 2021, Sep-17, Volume: 57, Issue:9 Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2021
Bleomycin Toxicity - Findings on FDG PET CT. JPMA. The Journal of the Pakistan Medical Association, 2021, Volume: 71, Issue:9 Topics: Bleomycin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Radiomic Features of Contrast media & molecular imaging, 2021, Volume: 2021 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Retrospective Studies	2021
All eyes on the EuroNet-PHL-C1 trial for paediatric classical Hodgkin lymphoma. The Lancet. Oncology, 2022, Volume: 23, Issue:1 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2022
Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine. Human vaccines & immunotherapeutics, 2021, Dec-02, Volume: 17, Issue:12 Topics: Adenoviridae; Adult; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; SARS-CoV-2	2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma. British journal of haematology, 2022, Volume: 197, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trials as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Progression-Free Survival	2022
First Extensive Analysis of Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 04-20, Volume: 40, Issue:12 Topics: Fluorodeoxyglucose F18; HIV Infections; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Retrospective Studies; Tumor Burden	2022
Optimal activity of [18F]FDG for Hodgkin lymphoma imaging performed on PET/CT camera with BGO crystals. Nuclear medicine review. Central & Eastern Europe, 2022, Volume: 25, Issue:1 Topics: Bayes Theorem; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
[Omission of radiotherapy depending on treatment response in children and adolescents with intermediate-stage and advanced-stage Hodgkin lymphoma. Comparison with other consolidation therapies (EuroNet-PHL-C1): a titration study]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2022, Volume: 198, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Consolidation Chemotherapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2022
Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake. PloS one, 2022, Volume: 17, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden	2022
[The choice of chemotherapy under PET/CT-guided treatment de-escalation has a significant impact on fertility and quality of life in young Hodgkin's lymphoma patients]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2022, Volume: 198, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Fertility; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quality of Life	2022
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study. Hematological oncology, 2022, Volume: 40, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Genomics; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Retrospective Studies; RNA; Vinblastine	2022
Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphoma. European radiology, 2022, Volume: 32, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Machine Learning; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Young Adult	2022
Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma. Acta oncologica (Stockholm, Sweden), 2022, Volume: 61, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Survival Analysis; Tomography, X-Ray Computed	2022
Clinical imaging, 2022, Volume: 92 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy	2022
Prognostic role of metabolic parameters (MTV and TLG) of staging PET/CT in the pediatric population with Hodgkin's lymphoma: an open discussion. European journal of nuclear medicine and molecular imaging, 2022, Volume: 50, Issue:1 Topics: Child; Fluorodeoxyglucose F18; Glycolysis; Hodgkin Disease; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2022
Progression or Response: New Liver Lesions in a Patient with Responding Hodgkin Lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023, Volume: 64, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2023
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma. Scientific reports, 2022, 10-21, Volume: 12, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Vinblastine	2022
The frequency of change in five-point scale score with a Bayesian penalised likelihood PET reconstruction algorithm on interim FDG PET-CT and its potential implications for therapy decisions in Hodgkin's lymphoma. Clinical radiology, 2023, Volume: 78, Issue:2 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine	2023
CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations. Scientific reports, 2022, 11-21, Volume: 12, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Tomography, X-Ray Computed	2022
End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET. Haematologica, 2023, 06-01, Volume: 108, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2023
Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma. Nuklearmedizin. Nuclear medicine, 2023, Volume: 62, Issue:1 Topics: Biopsy; Bone Marrow; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2023
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. International journal of radiation oncology, biology, physics, 2023, 08-01, Volume: 116, Issue:5 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions. PloS one, 2023, Volume: 18, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
Cerebellar Hypermetabolism in a Hodgkin Lymphoma Leads to Diagnosis of Paucisymptomatic Cryptococcus neoformans Meningitis. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Adult; Cryptococcus neoformans; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Meningitis; Paraneoplastic Cerebellar Degeneration; Positron Emission Tomography Computed Tomography	2023
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma. Pediatric blood & cancer, 2023, Volume: 70, Issue:8 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Hyperplasia; Thymus Neoplasms; Tomography, X-Ray Computed	2023
Correlation of mean apparent diffusion coefficient (ADC) and maximal standard uptake value (SUVmax) evaluated by diffusion-weighted MRI and 18F-FDG-PET/CT in children with Hodgkin lymphoma: a feasibility study. Radiology and oncology, 2023, 06-01, Volume: 57, Issue:2 Topics: Adolescent; Child; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies	2023
[Positron emission tomography: a central role in assessment and evaluation]. La Revue du praticien, 2023, Volume: 73, Issue:6 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2023
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma. Blood advances, 2023, 11-14, Volume: 7, Issue:21 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Progression-Free Survival; Transplantation, Autologous	2023
Revisiting the predictive role of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early-stage favorable Hodgkin lymphoma. Hematological oncology, 2023, Volume: 41, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Treatment Outcome; Vinblastine	2023
Can We Predict Bleomycin Toxicity with PET-CT? Acta haematologica, 2019, Volume: 142, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Vinblastine	2019
Value of detecting bone marrow involvement in Hodgkin lymphoma - Response to Adams and Kwee. British journal of haematology, 2019, Volume: 187, Issue:3 Topics: Bone Marrow; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2019
TAC y PET/TC con 18-FDG para evaluar la respuesta al tratamiento en linfoma de Hodgkin y no Hodgkin. Gaceta medica de Mexico, 2019, Volume: 155, Issue:4 Topics: Adolescent; Adult; Aged; Child; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2019
Value of detecting bone marrow involvement in Hodgkin lymphoma. British journal of haematology, 2019, Volume: 187, Issue:3 Topics: Bone Marrow; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe? Leukemia & lymphoma, 2020, Volume: 61, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine	2020
Only a Small Proportion of Patients With Early-Stage Hodgkin Lymphoma May Potentially Benefit From Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment Escalation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 12-01, Volume: 37, Issue:34 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Risk Assessment; United Kingdom	2019
PET-adapted treatment of Hodgkin lymphoma. Blood, 2019, 10-10, Volume: 134, Issue:15 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphadenopathy; Positron-Emission Tomography	2019
Would Negative Interim PET Be Enough to Omit Radiation in Patients With Early Hodgkin Lymphoma? The Answer Is No. International journal of radiation oncology, biology, physics, 2020, 01-01, Volume: 106, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography	2020
Deauville Dubiosity. International journal of radiation oncology, biology, physics, 2020, 01-01, Volume: 106, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography	2020
Diffusion-weighted MRI for initial staging in Hodgkin`s lymphoma: comparison with FDG PET. European journal of radiology, 2020, Volume: 123 Topics: Aged; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity	2020
Reply to E. Laffon Haematologica, 2020, Volume: 105, Issue:1 Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Mantle-Cell; Positron-Emission Tomography; Prognosis	2020
Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Nuclear medicine communications, 2020, Volume: 41, Issue:3 Topics: Adult; Aged; Bone Marrow Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult	2020
PET positivity - the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin lymphoma. Leukemia & lymphoma, 2020, Volume: 61, Issue:2 Topics: Biopsy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2020
Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma. Current medical imaging reviews, 2020, Volume: 16, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Retrospective Studies; Risk Assessment	2020
Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 04-01, Volume: 38, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2020
Computed tomography texture analysis for assessment of chemotherapy response of Hodgkin lymphoma. Medicine, 2020, Volume: 99, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult	2020
Interim PET Assessment of Advanced Hodgkin Lymphoma: Is It Sufficient? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:11 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography	2020
Whole-Body Diffusion-Weighted MRI Compared to Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2020, Volume: 71, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging	2020
Interim thymus and activation regulated chemokine versus interim British journal of haematology, 2020, Volume: 190, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemokines; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Progression-Free Survival; Thymus Gland; Young Adult	2020
Hounsfield units and fractal dimension (test HUFRA) for determining PET positive/negative lymph nodes in pediatric Hodgkin's lymphoma patients. PloS one, 2020, Volume: 15, Issue:3 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Fractals; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals	2020
FDG PET Is a Better Canary in the Coal Mine than CT for Refractory Lymphoma. Radiology, 2020, Volume: 295, Issue:3 Topics: Coal; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Nivolumab; Positron-Emission Tomography; Tomography, X-Ray Computed	2020
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients. Annals of hematology, 2020, Volume: 99, Issue:6 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies	2020
2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma. European journal of cancer (Oxford, England : 1990), 2020, Volume: 132 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Management; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Vinblastine; Young Adult	2020
Post-heart transplantation lymphoproliferative diseases (PTLDs) and the diagnostic role of [18f] FDG-PET/CT. Minerva medica, 2021, Volume: 112, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Heart Transplantation; Hodgkin Disease; Humans; Hyperplasia; Immunocompromised Host; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals	2021
Bone marrow involvement in pediatric malignancies: a comparison study of Positron emission tomographycomputed tomography and bone marrow biopsy. The Turkish journal of pediatrics, 2020, Volume: 62, Issue:2 Topics: Biopsy; Bone Marrow; Electrons; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2020
Incidental COVID-19 on PET/CT imaging. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, 06-08, Volume: 192, Issue:23 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Middle Aged; Neoplasm Staging; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; SARS-CoV-2	2020
Limiting surveillance imaging for patients with lymphoma in remission: a mixed methods study leading to a Choosing Wisely recommendation. BMJ quality & safety, 2021, Volume: 30, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2021
Incidental Discovery of a COVID-19 Infection on a Reevaluation FDG PET/CT in a Patient Treated for Hodgkin Lymphoma. Clinical nuclear medicine, 2020, Volume: 45, Issue:8 Topics: Adult; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; SARS-CoV-2	2020
18F-FDG PET/CT in Hodgkin Lymphoma With Unsuspected COVID-19. Clinical nuclear medicine, 2020, Volume: 45, Issue:8 Topics: Aged; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; SARS-CoV-2	2020
Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020, Volume: 150 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy Dosage; Treatment Outcome	2020
Clinical and prognostic role of interim 18F-FDG PET/CT in elderly Hodgkin lymphoma: a dual-center experience. Leukemia & lymphoma, 2020, Volume: 61, Issue:13 Topics: Aged; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies	2020
Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study. European radiology, 2021, Volume: 31, Issue:3 Topics: Child; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Reference Standards; Whole Body Imaging	2021
Reply: Interim PET Assessment of Advanced Hodgkin Lymphoma: Is It Sufficient? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:11 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography	2020
Sarcopenia in Hodgkin's lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021, Volume: 29, Issue:5 Topics: Adult; Age Factors; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcopenia; Young Adult	2021
Intense Increased 18F-FDG Uptake of Masticator Muscles After Cocaine Use. Clinical nuclear medicine, 2020, Volume: 45, Issue:11 Topics: Adult; Artifacts; Biological Transport; Cocaine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Masticatory Muscles; Positron Emission Tomography Computed Tomography	2020
Diffuse Subcutaneous Metabolic Activity in Post Bone Marrow Transplant Hodgkin Lymphoma. Clinical nuclear medicine, 2021, Apr-01, Volume: 46, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Diffusion; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Subcutaneous Tissue	2021
FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study. Medicine, 2020, Nov-25, Volume: 99, Issue:48 Topics: Adult; Anthracyclines; Antineoplastic Agents; Arteritis; Cardiovascular Diseases; Female; Fluorodeoxyglucose F18; HIV Infections; Hodgkin Disease; Humans; Hypertension; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Smoking	2020
Interim PET in Diffuse Large B-Cell Lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, 08-01, Volume: 62, Issue:8 Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography	2021
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: interobserver agreement and reproducibility across software platforms. Nuclear medicine communications, 2021, Mar-01, Volume: 42, Issue:3 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prognosis; Retrospective Studies; Software; Tumor Burden	2021
Prognostic value of imaging markers from 18FDG-PET/CT in paediatric patients with Hodgkin lymphoma. Nuclear medicine communications, 2021, Mar-01, Volume: 42, Issue:3 Topics: Adolescent; Adult; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies	2021
Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocol. BMJ open, 2021, 03-29, Volume: 11, Issue:3 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Italy; Multicenter Studies as Topic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals	2021
Comparison of 18F-labelled fluoro-2-deoxyglucose-PET with conventional computed tomography for staging and response assessment in paediatric and adult patients with nodular lymphocyte-predominant Hodgkin's lymphoma. Nuclear medicine communications, 2021, Aug-01, Volume: 42, Issue:8 Topics: Adult; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies	2021
Artificial intelligence could alert for focal skeleton/bone marrow uptake in Hodgkin's lymphoma patients staged with FDG-PET/CT. Scientific reports, 2021, 05-17, Volume: 11, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artificial Intelligence; Biological Transport; Biopsy; Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Musculoskeletal System; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skeleton; Young Adult	2021
Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of The British journal of radiology, 2021, Jul-01, Volume: 94, Issue:1123 Topics: Adipose Tissue; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Muscle, Skeletal; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sarcopenia; Software; Tomography, X-Ray Computed	2021
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031. Pediatric blood & cancer, 2021, Volume: 68, Issue:9 Topics: Adolescent; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2021
Outcomes Related to FDG-PET-CT Response in Patients With Hodgkin Lymphoma Treated With Brentuximab-Vedotin at Relapse or Consolidation. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:12 Topics: Adult; Brentuximab Vedotin; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Transplantation, Autologous	2021
Intravenacaval invasion of classical Hodgkin lymphoma detected with The Lancet. Oncology, 2017, Volume: 18, Issue:4 Topics: Adult; Chemoradiotherapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome; Vena Cava, Superior	2017
Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2017
FDG PET/CT Findings of Nodular Sclerosis-Subtype Classic Hodgkin Lymphoma Presented as Mediastinal Nodal Lesions at Onset But as Predominant Osseous Disease at Relapse. Clinical nuclear medicine, 2017, Volume: 42, Issue:6 Topics: Bone Diseases; Chronic Disease; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Recurrence; Sclerosis; Young Adult	2017
Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:8 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2017
FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:9 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2017
Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:9 Topics: Biopsy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Sarcoidosis	2017
The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:12 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; HIV Infections; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Tumor Burden; Young Adult	2017
Interim Fluorodeoxyglucose Positron Emission Tomography-Adapted Therapy Is Not an Efficient Approach to Improving Outcome in Early-Stage Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, 08-20, Volume: 35, Issue:24 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2017
Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma". European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:11 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2017
Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:11 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2017
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2021, Volume: 65, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Treatment Outcome	2021
Interim FDG-PET in lymphoma, a questionable practice in hematology. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hematology; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2017
Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee. British journal of haematology, 2018, Volume: 183, Issue:1 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies	2018
Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:12 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uncertainty	2017
Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma. British journal of haematology, 2018, Volume: 183, Issue:1 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals	2018
Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy. Leukemia & lymphoma, 2018, Volume: 59, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; In Vivo Dosimetry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Young Adult	2018
Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET". European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:13 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2017
Verbal fluency in research conducted with PET technique under conditions of extended cognitive activation with the use of 18F-fluorodeoxyglucose (FDG) tracer. Psychiatria polska, 2017, Aug-29, Volume: 51, Issue:4 Topics: Adult; Brain Mapping; Female; Fluorodeoxyglucose F18; Frontal Lobe; Hodgkin Disease; Humans; Male; Prefrontal Cortex; Speech Disorders; Temporal Lobe; Tomography, Emission-Computed; Verbal Behavior; Young Adult	2017
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood, 2018, 01-04, Volume: 131, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult	2018
The predictive value of interim FDG-PET in early-stage Hodgkin lymphoma is not well established. Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 02-01, Volume: 29, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Poland; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine	2018
Continued conundrum of PET-CT and Hodgkin's lymphoma. Lancet (London, England), 2017, 12-23, Volume: 390, Issue:10114 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed	2017
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging. Journal of magnetic resonance imaging : JMRI, 2018, Volume: 47, Issue:5 Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Hodgkin Disease; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging	2018
Relapsed/refractory HL: FDG-PET is the trump card. Blood, 2017, 11-16, Volume: 130, Issue:20 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography	2017
Testicular Estrogen-Secreting Leydig Cell Tumor in 18F-FDG PET/CT: An Incidental Detection in a Patient Treated by Chemotherapy for Hodgkin Lymphoma. Clinical nuclear medicine, 2018, Volume: 43, Issue:1 Topics: Estrogens; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Leydig Cell Tumor; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Testicular Neoplasms	2018
Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma: response to Adams and Kwee. British journal of haematology, 2019, Volume: 184, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine	2019
Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma. British journal of haematology, 2019, Volume: 184, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Vinblastine	2019
Baseline PET as prognostic marker for Hodgkin? Blood, 2018, 01-04, Volume: 131, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis	2018
Serious concerns on the inability of FDG-PET in excluding residual viable lymphoma. Annals of hematology, 2018, Volume: 97, Issue:5 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Positron-Emission Tomography; Prognosis; Tumor Burden	2018
Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma. European journal of cancer (Oxford, England : 1990), 2018, Volume: 91 Topics: Adult; Aged; Antineoplastic Agents, Immunological; Contrast Media; Female; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Kinetics; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult	2018
Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents? Pediatric radiology, 2018, Volume: 48, Issue:5 Topics: Adolescent; Child; Child, Preschool; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult	2018
Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at? Acta oncologica (Stockholm, Sweden), 2018, Volume: 57, Issue:8 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2018
FDG Accumulation in the Lumen of the Gallbladder Without Related Pathology. Clinical nuclear medicine, 2018, Volume: 43, Issue:5 Topics: Adolescent; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
Letter to the Editor: No Evidence to Promote Interim FDG-PET Adapted Therapy in the NCCN Guidelines for Hodgkin Lymphoma. Journal of the National Comprehensive Cancer Network : JNCCN, 2018, Volume: 16, Issue:3 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2018
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:10 Topics: Adolescent; Bone Marrow Neoplasms; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Induction Chemotherapy; Male; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome	2018
18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC). Medicine, 2018, Volume: 97, Issue:16 Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Israel; Lymphoid Tissue; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Tissue Distribution	2018
Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma. Nuclear medicine communications, 2018, Volume: 39, Issue:6 Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lactate Dehydrogenases; Lymphoma, B-Cell; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve	2018
Hounsfield units from unenhanced 18F-FDG-PET/CT are useful in evaluating supradiaphragmatic lymph nodes in children and adolescents with classical Hodgkin's lymphoma. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2018, Volume: 27, Issue:6 Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography	2018
Strikingly Heterogeneous Results Among Studies on Interim Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment in Advanced-Stage Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 07-10, Volume: 36, Issue:20 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Vinblastine	2018
Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD. Haematologica, 2018, Volume: 103, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy Dosage; Vinblastine; Young Adult	2018
Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18. Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 09-01, Volume: 29, Issue:9 Topics: Adolescent; Adult; Aged; Biopsy; Bone Marrow; Clinical Trials, Phase III as Topic; Datasets as Topic; Female; Fluorodeoxyglucose F18; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Reference Standards; Young Adult	2018
Hodgkin lymphoma staging 50 years later: no more knives or needles! Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 09-01, Volume: 29, Issue:9 Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Needles	2018
Paraneoplastic granulomatous dermatitis in a patient with Hodgkin's disease: a diagnostic pitfall. BMJ case reports, 2018, Aug-11, Volume: 2018 Topics: Aged; Anti-Inflammatory Agents; Back; Clobetasol; Diagnosis, Differential; Drug Therapy, Combination; Fluorodeoxyglucose F18; Granuloma Annulare; Hodgkin Disease; Humans; Male; Paraneoplastic Syndromes; Positron-Emission Tomography; Triamcinolone	2018
Solitary Benign Schwannoma Mimics Residual Malignancy on FDG PET/CT. Clinical nuclear medicine, 2018, Volume: 43, Issue:10 Topics: Adolescent; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm, Residual; Neurilemmoma; Positron Emission Tomography Computed Tomography	2018
18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma. Nuclear medicine communications, 2018, Volume: 39, Issue:11 Topics: Adult; Female; Fluorodeoxyglucose F18; HIV; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prognosis; Risk Assessment	2018
FDG PET in response evaluation of bulky masses in paediatric Hodgkin's lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:1 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome	2019
Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas. Clinical physiology and functional imaging, 2019, Volume: 39, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Automation; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Liver; Lymphoma, Non-Hodgkin; Male; Mediastinum; Middle Aged; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Treatment Outcome; Young Adult	2019
Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma. Clinical nuclear medicine, 2018, Volume: 43, Issue:12 Topics: Adolescent; Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals	2018
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline. Journal of translational medicine, 2018, 10-25, Volume: 16, Issue:1 Topics: Adult; Anthracyclines; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Muscles; Myocardium; Positron-Emission Tomography; Stroke Volume	2018
Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial. Pediatric blood & cancer, 2019, Volume: 66, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Survival Rate	2019
Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP. British journal of haematology, 2019, Volume: 185, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Procarbazine; Vincristine	2019
Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction? Nuclear medicine communications, 2019, Volume: 40, Issue:3 Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Tomography, X-Ray Computed; Young Adult	2019
Do Deauville Scores Improve the Clinical Utility of End-of-Therapy FDG PET Scans for Pediatric Hodgkin Lymphoma? AJR. American journal of roentgenology, 2019, Volume: 212, Issue:2 Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Time Factors; Young Adult	2019
Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT. Magma (New York, N.Y.), 2019, Volume: 32, Issue:3 Topics: Adolescent; Brain; Child; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Whole Body Imaging	2019
Comparison of Leukemia research, 2019, Volume: 76 Topics: Adult; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Young Adult	2019
Parapharyngeal Ganglioneuroma Detected by 18F-FDG PET/CT in a Patient With Hodgkin Lymphoma. Clinical nuclear medicine, 2019, Volume: 44, Issue:3 Topics: Adult; Female; Fluorodeoxyglucose F18; Ganglioneuroma; Hodgkin Disease; Humans; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:6 Topics: Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immune System; Immunotherapy; Nivolumab; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Recurrence; Retrospective Studies; Treatment Outcome	2019
Impact of acquisition count statistics reduction and SUV discretization on PET radiomic features in pediatric 18F-FDG-PET/MRI examinations. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2019, Volume: 59 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography	2019
Impact of rs12917 MGMT Polymorphism on [ Molecular imaging and biology, 2019, Volume: 21, Issue:6 Topics: Adolescent; Base Sequence; Cell Line, Tumor; Child; Child, Preschool; DNA Modification Methylases; DNA Repair Enzymes; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Tumor Suppressor Proteins	2019
Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019, Volume: 60, Issue:8 Topics: Congresses as Topic; Diagnostic Imaging; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Medical Oncology; Positron-Emission Tomography; Prognosis; Reference Standards; Risk Assessment; Software; Tomography, X-Ray Computed; Tumor Burden	2019
Evaluation of the effects of chemotherapy on brain glucose metabolism in children with Hodgkin's lymphoma. Annals of nuclear medicine, 2019, Volume: 33, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain; Child; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult	2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy. British journal of haematology, 2019, Volume: 186, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sweden; Treatment Outcome; Young Adult	2019
The Utility of PET/CT in Guiding Radiotherapy Reduction for Children With Hodgkin Lymphoma Treated With ABVD. Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Radiotherapy, Image-Guided; Retrospective Studies; Survival Rate; Vinblastine; Young Adult	2020
A Case of Sarcoidosis After Lymphoma. Clinical nuclear medicine, 2019, Volume: 44, Issue:8 Topics: Biopsy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Sarcoidosis	2019
Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma. ESC heart failure, 2019, Volume: 6, Issue:4 Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Muscle, Skeletal; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2019
Prognostic Value of Pretreatment Radiomic Features of 18F-FDG PET in Patients With Hodgkin Lymphoma. Clinical nuclear medicine, 2019, Volume: 44, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; ROC Curve; Young Adult	2019
The German evidence-based guidelines for Hodgkin's lymphoma. Aspects for radiation oncologists. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2013, Volume: 189, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cooperative Behavior; Evidence-Based Medicine; Fluorodeoxyglucose F18; Germany; Hodgkin Disease; Humans; Interdisciplinary Communication; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiotherapy Dosage	2013
2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation. Leukemia & lymphoma, 2014, Volume: 55, Issue:2 Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2014
The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma. Future oncology (London, England), 2013, Volume: 9, Issue:6 Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Radiography; Treatment Outcome	2013
Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT. Bone marrow transplantation, 2013, Volume: 48, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult	2013
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma. Leukemia & lymphoma, 2014, Volume: 55, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult	2014
Lungs on fire. BMJ case reports, 2013, Jun-27, Volume: 2013 Topics: Antibiotics, Antineoplastic; Bleomycin; Fatal Outcome; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Fibrosis; Radiopharmaceuticals	2013
Interim 18F-FDG PET in Hodgkin lymphoma: would PET-adapted clinical trials lead to a paradigm shift? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:7 Topics: Antineoplastic Agents; Clinical Trials as Topic; Evidence-Based Medicine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome	2013
Cerebral glucose metabolism on positron emission tomography of children. Human brain mapping, 2014, Volume: 35, Issue:5 Topics: Adolescent; Age Distribution; Analysis of Variance; Brain Mapping; Cerebral Cortex; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Infant; Male; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2014
[Predictive value of positron emission tomography with 18F-FDG in the diagnosis and staging of patients with Hodgkin's lymphoma]. Voprosy onkologii, 2013, Volume: 59, Issue:4 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2013
Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma. Cancer science, 2013, Volume: 104, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Vinblastine; Young Adult	2013
Comparison of the International Harmonization Project, London and Gallamini criteria in the interpretation of 18F-FDG PET/CT examinations after first-line treatment in Hodgkin's lymphoma. Nuclear medicine communications, 2014, Volume: 35, Issue:2 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2014
Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement. Leukemia & lymphoma, 2014, Volume: 55, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2014
Hodgkin lymphoma-associated paraneoplastic cerebellar degeneration on FDG-PET/CT. British journal of haematology, 2014, Volume: 164, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Radiography; Radiopharmaceuticals	2014
[Is ceCT necessary beyond FDG-PET/CT for primary staging in Hodgkin lymphoma?]. Orvosi hetilap, 2014, Feb-09, Volume: 155, Issue:6 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed	2014
Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:6 Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver; Male; Mediastinum; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vinblastine	2014
Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Agents; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis; Treatment Failure; Treatment Outcome; Young Adult	2014
Lymphoma and tuberculosis: temporal evolution of dual pathology on sequential 18F-FDG PET/CT. Clinical nuclear medicine, 2014, Volume: 39, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis	2014
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:6 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden	2014
Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:7 Topics: Adolescent; Biological Transport; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography	2014
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma. British journal of haematology, 2014, Volume: 165, Issue:6 Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult	2014
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Haematologica, 2014, Volume: 99, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult	2014
A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies. International journal of radiation oncology, biology, physics, 2014, Jun-01, Volume: 89, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasms, Plasma Cell; Nuclear Physics; Positron-Emission Tomography; Prospective Studies; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Recurrence; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2014
[Prognostic value of 18F-FDG PET-CT in Hodgkin lymphoma]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:4 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2014
CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment. Leukemia & lymphoma, 2015, Volume: 56, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Macrophages; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Treatment Outcome; Young Adult	2015
Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma. Leukemia & lymphoma, 2015, Volume: 56, Issue:2 Topics: Adult; Aged; Bone Marrow; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Spleen; Tomography, X-Ray Computed; Young Adult	2015
Primary Epstein-Barr virus infection diffusing F18-fluorodeoxyglucose-positron emission tomography/computed tomography response monitoring of Hodgkin's disease: a case report. Journal of medical case reports, 2014, Jun-20, Volume: 8 Topics: Asymptomatic Infections; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymph Nodes; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tomography, X-Ray Computed; Young Adult	2014
Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:11 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphocytes; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2014
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Sep-01, Volume: 32, Issue:25 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Vinblastine; Young Adult	2014
Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and Marthan. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:11 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography	2014
Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:11 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography	2014
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Sep-20, Volume: 32, Issue:27 Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2014
Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CT. Medicine, 2014, Volume: 93, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status. Hematological oncology, 2015, Volume: 33, Issue:4 Topics: Adolescent; Adult; Brentuximab Vedotin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Platinum; Positron-Emission Tomography; Prognosis; Treatment Outcome; Young Adult	2015
A strange case of phyllodes tumor detected using (18)F-FDG PET/CT in an adolescent patient affected by Hodgkin lymphoma: a possible pitfall. Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Phyllodes Tumor; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2014
FDG uptake in liposclerosing myxofibrous tumor causes upstaging of Hodgkin lymphoma. Clinical nuclear medicine, 2015, Volume: 40, Issue:4 Topics: Bone Neoplasms; Female; Femur; Fibroma; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2015
In vivo visualization of prostate-specific membrane antigen in glioblastoma. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:1 Topics: Antigens, Surface; Fluorodeoxyglucose F18; Glioblastoma; Glutamate Carboxypeptidase II; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution	2015
Decisional early interim (18)F-fluoro-2-deoxy-D-glucose positron emission tomography after two cycles of chemotherapy in de novo Hodgkin lymphoma. Acta haematologica, 2015, Volume: 133, Issue:2 Topics: Adolescent; Adult; Aged; Decision Making; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Survival Rate	2015
Liver SUV versus stage in Hodgkin's lymphoma: the total amount of uptake may play a role in the inverse relationship. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver; Male; Mediastinum; Radionuclide Imaging; Radiopharmaceuticals	2015
Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin's lymphoma: the total amount of uptake may play a role in the inverse relationship. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver; Male; Mediastinum; Radionuclide Imaging; Radiopharmaceuticals	2015
Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Annals of nuclear medicine, 2015, Volume: 29, Issue:2 Topics: Adult; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2015
CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma. International journal of hematology, 2015, Volume: 101, Issue:2 Topics: Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma; Male; Positron-Emission Tomography	2015
Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: comparison with F-18-FDG PET. Medical physics, 2014, Volume: 41, Issue:12 Topics: Adolescent; Adult; Biophysical Phenomena; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Imaging, Three-Dimensional; Logistic Models; Lymph Nodes; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2014
Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance. European journal of haematology, 2015, Volume: 95, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2015
Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-01, Volume: 33, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-01, Volume: 33, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Dealing with bone marrow biopsies in the staging of classical Hodgkin lymphoma: an old issue revisited in the (18)F-fluorodeoxyglucose-positron emission tomography era. Leukemia & lymphoma, 2015, Volume: 56, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult	2015
Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jun-01, Volume: 21, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiography; Whole Body Imaging	2015
Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy. Cancer, 2015, Jun-15, Volume: 121, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Diagnostic Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Vinblastine; Young Adult	2015
Untreated Hodgkin Lymphoma With Skin Infiltration and Satellite Skin Nodule in a 15-Year-Old Female Adolescent. Clinical nuclear medicine, 2015, Volume: 40, Issue:7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Vinblastine	2015
A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis. Tumori, 2015, Jun-25, Volume: 101, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Density Conservation Agents; Bone Marrow; Bone Neoplasms; Chronic Disease; Dacarbazine; Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Osteoblasts; Osteomyelitis; Pain; Pleural Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sacrum; Tomography, X-Ray Computed; Treatment Failure; Vinblastine	2015
The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. American journal of hematology, 2015, Volume: 90, Issue:8 Topics: Adolescent; Adult; Aged; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2015
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer. Clinical nuclear medicine, 2015, Volume: 40, Issue:8 Topics: Aged; Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Variability of Hepatic 18F-FDG Uptake at Interim PET in Patients With Hodgkin Lymphoma. Clinical nuclear medicine, 2015, Volume: 40, Issue:8 Topics: Adult; Aged; Analysis of Variance; Body Mass Index; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sex Factors	2015
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. International journal of radiation oncology, biology, physics, 2015, Aug-01, Volume: 92, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Regression Analysis; Remission Induction; Retrospective Studies; Time Factors; Vinblastine	2015
A Case Report of High 18F-FDG PET/CT Uptake in Progressive Transformation of the Germinal Centers. Medicine, 2015, Volume: 94, Issue:23 Topics: Aged; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of clinical and experimental hematopathology : JCEH, 2015, Volume: 55, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunophenotyping; Lymph Nodes; Lymphocytes; Male; Neoplasm Staging; Positron-Emission Tomography; Reed-Sternberg Cells; Transplantation, Autologous	2015
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment. Hematological oncology, 2017, Volume: 35, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Vinblastine; Young Adult	2017
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:2 Topics: Adolescent; Adult; Aged; Asymptomatic Diseases; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed	2016
Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma. La Radiologia medica, 2016, Volume: 121, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult	2016
Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation? Nuclear medicine communications, 2016, Volume: 37, Issue:1 Topics: Adolescent; Adult; Aged; Biological Transport; Biomarkers, Tumor; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Young Adult	2016
Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma. Nuclear medicine communications, 2016, Volume: 37, Issue:1 Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed; Young Adult	2016
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Regard to Simontacchi et al. International journal of radiation oncology, biology, physics, 2015, Nov-01, Volume: 93, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals	2015
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Reply to Adams and Kwee. International journal of radiation oncology, biology, physics, 2015, Nov-01, Volume: 93, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals	2015
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan. Acta haematologica, 2016, Volume: 135, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine	2016
Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:7 Topics: Adolescent; Biological Transport; Child; Child, Preschool; Diffusion; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Pilot Projects; Positron Emission Tomography Computed Tomography	2016
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study. Blood, 2016, Mar-24, Volume: 127, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Vinblastine	2016
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma. Cancer medicine, 2016, Volume: 5, Issue:3 Topics: Adolescent; Adult; Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocyte Subsets; Cell Count; Chemokine CCL17; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Positron-Emission Tomography; Treatment Outcome; Young Adult	2016
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Investigative radiology, 2016, Volume: 51, Issue:3 Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2016
Re: Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2016
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma. Journal of hematology & oncology, 2016, Mar-16, Volume: 9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Gene Frequency; Haplotypes; HLA Antigens; Hodgkin Disease; Homozygote; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Receptors, KIR; Vinblastine	2016
Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients. The British journal of radiology, 2016, Volume: 89, Issue:1061 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Vinblastine; Young Adult	2016
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: Reply. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:7 Topics: Adult; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocyte Depletion; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome	2016
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma. British journal of haematology, 2016, Volume: 174, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Young Adult	2016
Ovarian Hyperstimulation and Oocyte Harvesting Prior to Systemic Chemotherapy-A Possible Pitfall in 18F-FDG PET/CT Staging of Oncologic Patients. Clinical nuclear medicine, 2016, Volume: 41, Issue:8 Topics: Adult; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Oocyte Retrieval; Ovarian Neoplasms; Ovulation Induction; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Two Uncommon Paraneoplastic Neurological Syndromes in a Child With Hodgkin Lymphoma. Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:6 Topics: Adie Syndrome; Child; Esophageal Achalasia; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography	2016
Positive PET in a Patient With Esophageal Leiomyoma. The American journal of gastroenterology, 2016, Volume: 111, Issue:6 Topics: Adult; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leiomyoma; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdominal radiology (New York), 2016, Volume: 41, Issue:7 Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2016
18F-FDG PET/CT Imaging of Hodgkin Lymphoma in a Child with Common Variable Immunodeficiency. Journal of nuclear medicine technology, 2016, Volume: 44, Issue:4 Topics: Child; Common Variable Immunodeficiency; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography	2016
CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas. European radiology, 2017, Volume: 27, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed; Young Adult	2017
Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients? Nuclear medicine communications, 2016, Volume: 37, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2016
Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation. British journal of haematology, 2016, Volume: 175, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease Management; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Treatment Failure; Treatment Outcome; Vinblastine; Young Adult	2016
Serendipitous Detection of Hodgkin Lymphoma by 18F-NaF PET/CT. Clinical nuclear medicine, 2016, Volume: 41, Issue:10 Topics: Adolescent; Calcinosis; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride	2016
End-of-treatment FDG-PET lacks usefulness in Hodgkin lymphoma. Annals of hematology, 2016, Volume: 95, Issue:12 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Treatment Outcome	2016
Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. The New England journal of medicine, 2016, 09-08, Volume: 375, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Tomography, X-Ray Computed	2016
Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. The New England journal of medicine, 2016, 09-08, Volume: 375, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Tomography, X-Ray Computed	2016
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma. Clinical nuclear medicine, 2017, Volume: 42, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Splenic Neoplasms; Young Adult	2017
High-risk interim PET negative patients in Hodgkin's lymphoma. The Lancet. Haematology, 2016, Volume: 3, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed	2016
Reply. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1 Topics: Adolescent; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Risk Assessment	2017
Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? - Wait for confirmation study : Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1 Topics: Adolescent; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Risk Assessment	2017
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients. British journal of haematology, 2018, Volume: 180, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukocyte Count; Monocytes; Positron-Emission Tomography; Prognosis; Proportional Hazards Models	2018
Diffuse 18F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma. BMJ case reports, 2016, Oct-28, Volume: 2016 Topics: Bone Marrow; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2016
Update on the use of FDG-PET/CT in malignant lymphoma. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2016, Volume: 57, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice? Haematologica, 2016, Volume: 101, Issue:11 Topics: Biomarkers; Clinical Studies as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis	2016
Reply: Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2017
Cat-Scratch Disease: A Pitfall for Lymphoma Evaluation by FDG-PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:2 Topics: Adult; Cat-Scratch Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations? British journal of haematology, 2018, Volume: 181, Issue:1 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2018
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. International journal of radiation oncology, biology, physics, 2017, 02-01, Volume: 97, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Recurrence; Risk; Treatment Outcome; Tumor Burden; Vinblastine	2017
Predictive Value of Interim [ Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, 01-20, Volume: 35, Issue:3 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2017
Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations? - Response to Adams & Kwee. British journal of haematology, 2018, Volume: 181, Issue:1 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2018
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Internationality; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radioactive Tracers; Retrospective Studies; Young Adult	2017
Pediatric Hodgkin Lymphoma: Predictive value of interim 18F-FDG PET/CT in therapy response assessment. Medicine, 2017, Volume: 96, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Child; Child, Preschool; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Treatment Outcome	2017
Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma. Leukemia & lymphoma, 2017, Volume: 58, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Bleomycin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Pneumonia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Young Adult	2017
Early warning signs: FDG-PET to diagnose bleomycin toxicity. Leukemia & lymphoma, 2017, Volume: 58, Issue:5 Topics: Bleomycin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2017
Predicting outcomes after a positive interim FDG-PET scan in advanced Hodgkin's lymphoma. The Lancet. Oncology, 2017, Volume: 18, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2017
Pediatric Brown Adipose Tissue on Journal of nuclear medicine technology, 2017, Volume: 45, Issue:2 Topics: Adipose Tissue, Brown; Adolescent; Artifacts; Biological Transport; Diazepam; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Retrospective Studies	2017
Reply: Interim PET in Hodgkin Lymphoma: Is It So Useless? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:7 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography	2017
The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2008, Volume: 88, Issue:2 Topics: Contrast Media; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Practice Guidelines as Topic; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2008
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. Annals of nuclear medicine, 2008, Volume: 22, Issue:5 Topics: Adolescent; False Negative Reactions; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence	2008
New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. Radiologic clinics of North America, 2008, Volume: 46, Issue:2 Topics: Clinical Trials as Topic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed	2008
Elevated FDG uptake in Kaposi sarcoma mimicking Hodgkin's lymphoma relapse. Clinical nuclear medicine, 2008, Volume: 33, Issue:9 Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Sarcoma, Kaposi; Tomography, X-Ray Computed	2008
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. Nuclear medicine communications, 2008, Volume: 29, Issue:8 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Ultrasonography	2008
[18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas. Clinical lymphoma & myeloma, 2008, Volume: 8, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Time Factors	2008
[Role of 18F-FDG PET in tumor grading and evaluating effectiveness of therapy in malignant lymphomas]. Voprosy onkologii, 2008, Volume: 54, Issue:4 Topics: Adult; Aged; Female; Fibrosis; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Spiral Computed; Treatment Outcome	2008
[FDG-PET in Hodgkin lymphoma]. Nuklearmedizin. Nuclear medicine, 2008, Volume: 47, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Limited-stage disease: optimal use of chemotherapy and radiation treatment. Hematology. American Society of Hematology. Education Program, 2008 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Radiotherapy; Risk Assessment; Vinblastine	2008
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. Cancer biotherapy & radiopharmaceuticals, 2008, Volume: 23, Issue:6 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission. Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:1 Topics: Biopsy; Child; False Positive Reactions; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy. British journal of haematology, 2009, Volume: 145, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Salvage Therapy	2009
Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. Radiology, 2009, Volume: 251, Issue:2 Topics: Adolescent; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tomography, X-Ray Computed; Ultrasonography; Young Adult	2009
Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma. Oncology research, 2009, Volume: 17, Issue:7 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucose Transporter Type 3; Hexokinase; Hodgkin Disease; Humans; Immunoenzyme Techniques; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reed-Sternberg Cells; Young Adult	2009
Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma. Annals of hematology, 2009, Volume: 88, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2009
[Impact of FDG-PET on radiation therapy: economic results of a STIC study]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2009, Volume: 13, Issue:4 Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Lung Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Child; Diffusion; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Spleen; Tomography, X-Ray Computed; Young Adult	2009
Primary mediastinal Hodgkin lymphoma and rebound thymic hyperplasia: differentiation with chemical-shift magnetic resonance imaging after treatment. International journal of hematology, 2009, Volume: 90, Issue:1 Topics: Adult; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Remission Induction	2009
Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography. Nuclear medicine communications, 2009, Volume: 30, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glucose Transporter Type 3; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography	2009
[FDG PET/CT and childhood Hodgkin lymphoma]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2009, Volume: 16, Issue:6 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Vinblastine	2009
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil. Clinics (Sao Paulo, Brazil), 2009, Volume: 64, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging; Young Adult	2009
[18F-FDG uptake of lymphoma lesions of various histological subtypes]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ki-67 Antigen; Lymphoma, B-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2009
Occult Hodgkin lymphoma presenting as polymyalgia rheumatica: value of [18F]-FDG positron emission tomography. Annals of hematology, 2010, Volume: 89, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Polymyalgia Rheumatica; Positron-Emission Tomography	2010
Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-10, Volume: 27, Issue:26 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Time Factors	2009
Absence of residual Hodgkin's disease demonstrated by PET/CT in a deceased organ donor. Transplant international : official journal of the European Society for Organ Transplantation, 2010, Volume: 23, Issue:1 Topics: Adult; Brain Death; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tissue and Organ Procurement; Tissue Donors; Tomography, X-Ray Computed	2010
Diffuse cavitary lung lesions. Pediatric radiology, 2010, Volume: 40, Issue:2 Topics: Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed	2010
On the added value of baseline FDG-PET in malignant lymphoma. Molecular imaging and biology, 2010, Volume: 12, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Whole Body Imaging; Young Adult	2010
Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. The oncologist, 2009, Volume: 14 Suppl 2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2009
Is there a role for bone scan in Hodgkin lymphoma in the age of 18F-fluorodeoxyglucose positron emission tomography? Leukemia & lymphoma, 2009, Volume: 50, Issue:11 Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2009
Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes. Leukemia & lymphoma, 2009, Volume: 50, Issue:11 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Treatment Outcome	2009
Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation. Leukemia & lymphoma, 2009, Volume: 50, Issue:11 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reference Standards; Reproducibility of Results; Treatment Outcome	2009
Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. Leukemia & lymphoma, 2009, Volume: 50, Issue:11 Topics: Adolescent; Bone and Bones; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2009
[Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long-term follow-up results]. Orvosi hetilap, 2009, Nov-22, Volume: 150, Issue:47 Topics: Adolescent; Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Young Adult	2009
Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed	2010
[Malignant lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:13 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2009
FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics : a review publication of the Radiological Society of North America, Inc, 2010, Volume: 30, Issue:1 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Young Adult	2010
Role of FDG-PET/CT in management of Hodgkin's lymphoma. Indian journal of pediatrics, 2009, Volume: 76, Issue:12 Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Interpretation and validation of interim positron emission tomography in Hodgkin lymphoma. Leukemia & lymphoma, 2010, Volume: 51, Issue:3 Topics: Antineoplastic Agents; Clinical Trials as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multicenter Studies as Topic; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reference Standards; Reproducibility of Results	2010
The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:1 Topics: Adolescent; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2011
Tracheobronchial papillomatosis with diffuse cavitary lung lesions. Pediatric radiology, 2010, Volume: 40, Issue:7 Topics: Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed	2010
(18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2010
Absorbed 18F-FDG dose to the fetus during early pregnancy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:5 Topics: Adult; Female; Fetus; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Photons; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First; Radiometry; Radiopharmaceuticals; Tomography, Emission-Computed	2010
Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases. Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome	2010
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma. Haematologica, 2010, Volume: 95, Issue:7 Topics: Adolescent; Adult; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Young Adult	2010
The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. The Laryngoscope, 2010, Volume: 120, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Glucose; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2010
Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long term follow-up results. Neoplasma, 2010, Volume: 57, Issue:4 Topics: Adolescent; Adult; Aged; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Time Factors; Treatment Outcome; Young Adult	2010
Retrospective evaluation of PET-MRI registration algorithms. Journal of digital imaging, 2011, Volume: 24, Issue:3 Topics: Algorithms; Brain; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lymphoma; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies	2011
Impact of 18F-fluoro-2-deoxyglucose positron emission tomography on treatment strategy and radiotherapy planning for stage I-II Hodgkin disease: a prospective multicenter study. International journal of radiation oncology, biology, physics, 2011, Mar-01, Volume: 79, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2011
Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis. Cancer, 2010, Aug-15, Volume: 116, Issue:16 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2010
Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition. International journal of radiation oncology, biology, physics, 2011, Jul-01, Volume: 80, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Observer Variation; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Vinblastine; Vincristine	2011
Role of FDG-PET in the definition of involved-field radiation therapy and management for pediatric Hodgkin's lymphoma. International journal of radiation oncology, biology, physics, 2011, Jun-01, Volume: 80, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed	2011
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contrast Media; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Liver; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Recurrence; Spleen; Tomography, X-Ray Computed; Young Adult	2011
Predicting the clinical course of Hodgkin lymphoma. Nature reviews. Clinical oncology, 2010, Volume: 7, Issue:8 Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers, Tumor; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunohistochemistry; Macrophages; Positron-Emission Tomography; Prognosis; Treatment Outcome	2010
Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT. Clinical nuclear medicine, 2010, Volume: 35, Issue:9 Topics: Adolescent; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kidney Transplantation; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging	2010
The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Annals of hematology, 2011, Volume: 90, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Remission Induction; Survival Rate; Tomography, X-Ray Computed; Young Adult	2011
Unusual discrepancy between CT and PET/CT in the initial staging of Hodgkin's lymphoma. Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:3 Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed	2011
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multicenter Studies as Topic; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Research Design; United Kingdom	2011
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma. Bone marrow transplantation, 2011, Volume: 46, Issue:6 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult	2011
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report. Pediatric hematology and oncology, 2010, Volume: 27, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Fluorodeoxyglucose F18; Gemcitabine; Hodgkin Disease; Humans; Positron-Emission Tomography; Recurrence; Research Report; Retrospective Studies; Survival Analysis; Vinblastine; Vinorelbine	2010
[¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies. International journal of radiation oncology, biology, physics, 2011, Nov-01, Volume: 81, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasms, Plasma Cell; New York City; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2011
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Internationality; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2011
Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma. International journal of hematology, 2011, Volume: 93, Issue:4 Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2011
Bilateral breast involvement of Hodgkin lymphoma revealed by FDG PET/CT. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2 Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival. Annals of hematology, 2011, Volume: 90, Issue:11 Topics: Adolescent; Adult; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Salvage Therapy; Survival Rate; Transplantation, Autologous; Young Adult	2011
Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:8 Topics: Adolescent; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2011
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:9 Topics: Adolescent; Child; Child, Preschool; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; ROC Curve; Treatment Outcome; Young Adult	2011
Influence of reconstruction settings on the performance of adaptive thresholding algorithms for FDG-PET image segmentation in radiotherapy planning. Journal of applied clinical medical physics, 2011, Jan-30, Volume: 12, Issue:2 Topics: Algorithms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Models, Statistical; Normal Distribution; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Regression Analysis; Tomography, X-Ray Computed; Urinary Bladder	2011
Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; Salvage Therapy; Transplantation, Autologous; Young Adult	2011
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy. Leukemia & lymphoma, 2011, Volume: 52, Issue:9 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Young Adult	2011
Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone. Leukemia & lymphoma, 2012, Volume: 53, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiopharmaceuticals; Time Factors; Treatment Outcome; Vincristine; Young Adult	2012
Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging? Leukemia & lymphoma, 2011, Volume: 52, Issue:11 Topics: Algorithms; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Positron emission tomography features of hidradenitis suppurativa. The British journal of radiology, 2011, Volume: 84, Issue:1004 Topics: Adult; Fluorodeoxyglucose F18; Hidradenitis Suppurativa; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals	2011
Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions. Clinical lymphoma, myeloma & leukemia, 2011, Volume: 11, Issue:4 Topics: Adolescent; Biopsy; Bone Marrow; Brazil; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2011
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Sep-10, Volume: 29, Issue:26 Topics: Adolescent; Biopsy; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity	2011
Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma. Pediatric blood & cancer, 2012, Volume: 58, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2012
"Pet negativity"--the new goal of cytoreductive therapy in Hodgkin's lymphoma? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Salvage Therapy	2011
Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era. Leukemia & lymphoma, 2012, Volume: 53, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow Examination; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Health Care Surveys; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Practice Patterns, Physicians'; Predictive Value of Tests; Radiopharmaceuticals; Surveys and Questionnaires; United Kingdom; Unnecessary Procedures; Young Adult	2012
Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Time Factors; Vinblastine; Young Adult	2012
PET imaging in a longitudinal non-Hodgkin's lymphoma study: association with tumor volume. Acta radiologica (Stockholm, Sweden : 1987), 2011, Nov-01, Volume: 52, Issue:9 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Tumor Burden	2011
Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma. British journal of haematology, 2012, Volume: 156, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diffusion Magnetic Resonance Imaging; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Vincristine	2012
Response to "Role of FDG-PET in the definition and management of involved-field radiation therapy for pediatric Hodgkin's lymphoma."Int J Radiat Oncol Biol Phys (2011;80:324-332). International journal of radiation oncology, biology, physics, 2012, Jan-01, Volume: 82, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals	2012
SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: is there a benefit for PPV in early response assessment by FDG-PET? Pediatric blood & cancer, 2012, Volume: 59, Issue:3 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies	2012
Clinical utility of ¹⁸F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma. The British journal of radiology, 2012, Volume: 85, Issue:1016 Topics: Adolescent; Adult; Aged; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2012
Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease. Radiation oncology (London, England), 2012, Jan-19, Volume: 7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult	2012
Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma. La Radiologia medica, 2012, Volume: 117, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine	2012
Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection. AIDS (London, England), 2012, Apr-24, Volume: 26, Issue:7 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine	2012
High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors. Hematological oncology, 2013, Volume: 31, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult	2013
Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl. Klinische Padiatrie, 2012, Volume: 224, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Mediastinal Neoplasms; Multimodal Imaging; Neoplasm Staging; Nephrotic Syndrome; Positron-Emission Tomography; Prednisone; Tomography, X-Ray Computed; Vincristine	2012
Interim response assessment for Hodgkin lymphoma: size matters. Leukemia & lymphoma, 2012, Volume: 53, Issue:11 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
[Diagnostic difficulties caused by a pulmonary infiltrate]. Orvosi hetilap, 2012, Jul-08, Volume: 153, Issue:27 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Fever of Unknown Origin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine	2012
The diagnostic value of FDG-PET cannot be judged by iliac bone marrow biopsy. The British journal of radiology, 2012, Volume: 85, Issue:1016 Topics: Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
PET/MRI: challenges, solutions and perspectives. Zeitschrift fur medizinische Physik, 2012, Volume: 22, Issue:4 Topics: Alzheimer Disease; Animals; Brain; Carbon Radioisotopes; Contrast Media; Diffusion Magnetic Resonance Imaging; Efficiency; Electron Spin Resonance Spectroscopy; Equipment Design; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Animal; Multimodal Imaging; Positron-Emission Tomography; Raclopride; Rats; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult	2012
Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials? Blood, 2012, Dec-13, Volume: 120, Issue:25 Topics: Antineoplastic Agents; Clinical Trials as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis	2012
Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma. Leukemia & lymphoma, 2013, Volume: 54, Issue:4 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult	2013
The role of FDG-PET and bone marrow examination in lymphoma staging. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23 Suppl 10 Topics: Biopsy; Bone Marrow; Bone Marrow Examination; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed	2012
ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma. Cancer, 2013, Mar-15, Volume: 119, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiation Monitoring; Radiography; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Young Adult	2013
A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma. Leukemia, 2013, Volume: 27, Issue:6 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Stem Cell Transplantation; Treatment Outcome; Young Adult	2013
Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma. Annals of nuclear medicine, 2013, Volume: 27, Issue:2 Topics: Adolescent; Bone Marrow; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2013
Hodgkin lymphoma: protecting the victims of our success. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Dec-20, Volume: 30, Issue:36 Topics: Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Radionuclide Imaging	2012
Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Dec-20, Volume: 30, Issue:36 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Cohort Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2012
Early interim FDG PET/CT prediction of treatment response and prognosis in pediatric Hodgkin disease-added value of low-dose CT. Pediatric radiology, 2013, Volume: 43, Issue:1 Topics: Adolescent; Child; Child, Preschool; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
The role of FDG-PET scanning in assessing lymphoma in 2012. Diagnostic and interventional imaging, 2013, Volume: 94, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome	2013
[Diagnostic usefulness of FDG-PET/CT in multiple primary osseous Hodgkin lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:12 Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma. Acta haematologica, 2013, Volume: 129, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prednisone; ROC Curve; Tomography, X-Ray Computed; Vincristine	2013
Staging and monitoring in the treatment of lymphomas. Diagnostic and interventional imaging, 2013, Volume: 94, Issue:2 Topics: Biopsy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image-Guided Biopsy; Interdisciplinary Communication; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Neoplasm Staging; Neoplasm, Residual; Radiography; Radionuclide Imaging; Treatment Outcome	2013
A rare case of primary thymic Hodgkin lymphoma in an elderly patient detected by 18F-FDG PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:5 Topics: Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Thymus Neoplasms; Tomography, X-Ray Computed	2013
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Retrospective Studies; Sperm Count; Testis; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult	2013
Challenging cases and diagnostic dilemmas: case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-01, Volume: 20, Issue:15 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Hodgkin Disease; Humans; Mediastinal Diseases; Tomography, Emission-Computed	2002
Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation. Leukemia & lymphoma, 2002, Volume: 43, Issue:6 Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Recurrence; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2002
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Treatment Outcome	2002
Assessment of Lymphoma Therapy Using (18)F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Recurrent lymphoma detected on F-18 FDG coincidence imaging with negative findings on Ga-67 citrate scintigraphy. Clinical nuclear medicine, 2002, Volume: 27, Issue:9 Topics: Adult; Citrates; False Negative Reactions; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Humans; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radionuclide Imaging; Radiopharmaceuticals	2002
[(18)F]FDG in childhood lymphoma: clinical utility and impact on management. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:9 Topics: Adult; Age Factors; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Simultaneous occurrence of Hodgkin's lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging. Clinical lymphoma, 2002, Volume: 3, Issue:2 Topics: Adult; Eosinophilic Granuloma; Eosinophils; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Islets of Langerhans; Lymphoma; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
Does positron emission tomogrpahy have a role in routine clinical practice in patients with Hodgkin's disease? Clinical lymphoma, 2002, Volume: 3, Issue:2 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Positron emission tomography for the staging of Hodgkin's lymphoma--increasing the body of evidence in favor of the method. Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:5 Topics: Adolescent; Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2002
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:1 Topics: Adolescent; Adult; Aged; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radiopharmaceuticals; Thymus Gland; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
Positron emission tomography in the management of lymphomas. Clinical oncology (Royal College of Radiologists (Great Britain)), 2002, Volume: 14, Issue:5 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma. Acta medica Austriaca, 2003, Volume: 30, Issue:2 Topics: Adolescent; Adult; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, Emission-Computed	2003
Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging. Clinical nuclear medicine, 2003, Volume: 28, Issue:8 Topics: Adolescent; Bone Marrow; Bone Marrow Neoplasms; Cytokines; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hematopoiesis; Hodgkin Disease; Humans; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome	2003
[Evaluation of bone marrow involvement by FDG-PET for refractory Hodgkin lymphoma treated by unrelated allogeneic bone marrow transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Radiopharmaceuticals; Tomography, Emission-Computed; Transplantation, Homologous	2003
Case report: PET scan detects prostate cancer in a patient with Hodgkins lymphoma. Annals of clinical and laboratory science, 2003,Summer, Volume: 33, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Male; Middle Aged; Neoplasms, Multiple Primary; Prostatic Neoplasms; Tomography, Emission-Computed	2003
FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy. International journal of radiation oncology, biology, physics, 2003, Oct-01, Volume: 57, Issue:2 Topics: Adolescent; Adult; Aged; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, Emission-Computed	2003
FDG PET for imaging pericardial manifestations of Hodgkin lymphoma. Clinical nuclear medicine, 2003, Volume: 28, Issue:9 Topics: Fluorodeoxyglucose F18; Heart Neoplasms; Hodgkin Disease; Humans; Male; Middle Aged; Pericardium; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Positron emission tomography in patients with Hodgkin's disease: correlation to histopathologic subtypes. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:4 Topics: Adolescent; Adult; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2003
Increased metabolic activity in the spinal cord of patients with long-standing Lhermitte's sign. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2003, Volume: 179, Issue:10 Topics: Adult; Female; Fibroblasts; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Methionine; Nasopharyngeal Neoplasms; Radiation Injuries; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Spinal Cord; Spinal Cord Diseases; Time Factors; Tomography, Emission-Computed	2003
Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence - consequences for the GPOH-HD 2003 protocol. Onkologie, 2003, Volume: 26, Issue:5 Topics: Adolescent; Blood Glucose; Child; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Staging; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting	2003
The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma. Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:6 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2003
Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. British journal of cancer, 2004, Feb-09, Volume: 90, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Decision Making; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals	2004
Hodgkin disease in the sinonasal region detected by FDG PET. Clinical nuclear medicine, 2004, Volume: 29, Issue:7 Topics: Adult; Female; Fluorodeoxyglucose F18; Frontal Sinus; Hodgkin Disease; Humans; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2004
Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:1 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neck; Radiopharmaceuticals; Thorax; Tomography, Emission-Computed	2004
Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clinical lymphoma, 2004, Volume: 5, Issue:1 Topics: Biological Transport; Bone Marrow; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Hyperplasia; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed	2004
Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? Radiology, 2004, Volume: 232, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology, 2004, Jul-27, Volume: 63, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed	2004
Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin's disease: hepatic 'superscan'. Clinical nuclear medicine, 2004, Volume: 29, Issue:10 Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals	2004
Can[18F] fluorodeoxyglucose positron emission tomography replace bone marrow biopsy in staging of malignant lymphoma? Clinical lymphoma, 2004, Volume: 5, Issue:2 Topics: Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Radiopharmaceuticals	2004
[PET/CT in lymphoma patients]. Der Radiologe, 2004, Volume: 44, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Child; Child, Preschool; Equipment Design; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2004
Coincidence-detection FDG-PET versus gallium in children and young adults with newly diagnosed Hodgkin's disease. Pediatric radiology, 2005, Volume: 35, Issue:2 Topics: Adolescent; Adult; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Spleen; Tomography, Emission-Computed, Single-Photon	2005
Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses. Acta haematologica, 2004, Volume: 112, Issue:4 Topics: Child; Child, Preschool; Diagnostic Errors; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Male; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Rate	2004
Intense F-18 FDG accumulation in stomach in a patient with Hodgkin lymphoma: Helicobacter pylori infection as a pitfall in oncologic diagnosis with F-18 FDG PET imaging. Clinical nuclear medicine, 2005, Volume: 30, Issue:1 Topics: Adult; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Stomach; Stomach Neoplasms	2005
18F-FDG PET in children with lymphomas. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:1 Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2005
18F-FDG PET early after radiotherapy in lymphoma patients. Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:5 Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2004
Staging in childhood lymphoma: differences between FDG-PET and CT. Nuklearmedizin. Nuclear medicine, 2005, Volume: 44, Issue:1 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2005
Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions. British journal of haematology, 2005, Volume: 128, Issue:6 Topics: Adult; Biopsy; Bone Marrow Transplantation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunotherapy, Adoptive; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Transplantation, Homologous	2005
18F-FDG PET in malignant lymphoma: significance of positive findings. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:7 Topics: Adolescent; Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome	2005
[Hodgkin's disease with bone marrow involvement. The role of positron tomography]. Presse medicale (Paris, France : 1983), 2005, Feb-12, Volume: 34, Issue:3 Topics: Adult; Bone Marrow Neoplasms; Fever; Fluorodeoxyglucose F18; Health Status; Hodgkin Disease; Humans; Male; Pancytopenia; Positron-Emission Tomography; Radiopharmaceuticals	2005
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET? Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2005
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2006
[The value of integrated PET-CT images in 2 lymphoma patients with skeletal localisations]. Nederlands tijdschrift voor geneeskunde, 2006, Jan-28, Volume: 150, Issue:4 Topics: Adult; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2006
F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatric radiology, 2006, Volume: 36, Issue:6 Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2006
Diffuse bowel fluorodeoxyglucose uptake on positron emission tomography scan following allogeneic stem cell transplant. British journal of haematology, 2006, Volume: 133, Issue:3 Topics: Adult; Fluorodeoxyglucose F18; Graft vs Host Disease; Hodgkin Disease; Humans; Male; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Radiopharmaceuticals	2006
(18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies. Nuklearmedizin. Nuclear medicine, 2006, Volume: 45, Issue:3 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2006
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone marrow transplantation, 2006, Volume: 38, Issue:3 Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome	2006
Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:5 Topics: Adolescent; Child; Child, Preschool; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity	2006
"Cold" vertebrae on F-18 FDG PET: Causes and characteristics. Clinical nuclear medicine, 2006, Volume: 31, Issue:8 Topics: Adenocarcinoma; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioma; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spine	2006
Focally enhanced f-18 fluorodeoxyglucose (FDG) uptake in incidentally detected pulmonary embolism on PET/CT scanning. Clinical nuclear medicine, 2006, Volume: 31, Issue:8 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Lung Neoplasms; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed	2006
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease. Annals of hematology, 2006, Volume: 85, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, Emission-Computed	2006
PET positive progressive transformation of germinal centers masquerading as relapsed Hodgkin lymphoma post-autograft. Leukemia & lymphoma, 2006, Volume: 47, Issue:4 Topics: Cell Transformation, Neoplastic; Diagnosis, Differential; Fluorodeoxyglucose F18; Germinal Center; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Remission Induction; Transplantation, Autologous	2006
FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis. Journal of thoracic imaging, 2006, Volume: 21, Issue:3 Topics: Antibiotics, Antineoplastic; Bleomycin; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Diseases; Middle Aged; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2006
Pitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case report. Haematologica, 2006, Volume: 91, Issue:8 Suppl Topics: Contraindications; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence	2006
Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments? Cancer, 2006, Oct-01, Volume: 107, Issue:7 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Treatment Outcome	2006
FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre. Acta oncologica (Stockholm, Sweden), 2006, Volume: 45, Issue:6 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Sweden; Tomography, X-Ray Computed	2006
PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiography, Abdominal; Sclerosis; Tomography, X-Ray Computed	2006
Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma. British journal of haematology, 2006, Volume: 135, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2006
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease. Cancer, 2006, Dec-01, Volume: 107, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Retrospective Studies; Vincristine	2006
Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:11 Topics: Adolescent; Adult; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies	2006
Hodgkin's and non-Hodgkin's lymphomas. Radiologic clinics of North America, 2007, Volume: 45, Issue:1 Topics: Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Treatment Outcome	2007
[Iatrogenic lung microembolism detected by 18FDG PET/CT]. Revista espanola de medicina nuclear, 2006, Volume: 25, Issue:5 Topics: Adult; Diagnosis, Differential; Endothelium, Vascular; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Iatrogenic Disease; Injections, Intravenous; Lung Neoplasms; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals	2006
18F-fluorodeoxyglucose-Avid mammary mass in a patient with insulin-dependent diabetes mellitus and Hodgkin's lymphoma: relapse or pitfall? The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:12 Topics: Adult; Breast Neoplasms, Male; Diabetes Complications; Diabetes Mellitus, Type 1; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Tomography, Emission-Computed	2006
Revised response criteria for malignant lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Feb-10, Volume: 25, Issue:5 Topics: Clinical Trials as Topic; Endpoint Determination; Flow Cytometry; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Terminology as Topic; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2007
Muscular FDG uptake after chewing chewing gum in a patient with Hodgkin disease. Clinical nuclear medicine, 2007, Volume: 32, Issue:2 Topics: Adult; Artifacts; Chewing Gum; Fluorodeoxyglucose F18; Head; Hodgkin Disease; Humans; Male; Muscles; Neck; Radionuclide Imaging; Radiopharmaceuticals	2007
Comparison of positron emission tomography and lymphangiography in the diagnosis of infradiaphragmatic Hodgkin's disease. Acta radiologica (Stockholm, Sweden : 1987), 2007, Volume: 48, Issue:1 Topics: Adolescent; Adult; Diaphragm; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kidney; Lymph Nodes; Lymphography; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Spleen	2007
Unsuspected bone and soft tissue lesions identified at cancer screening using positron emission tomography. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:3 Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Soft Tissue Neoplasms	2007
Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma. Leukemia & lymphoma, 2007, Volume: 48, Issue:4 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radionuclide Imaging; Tomography, X-Ray Computed	2007
Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: a single center experience. Leukemia & lymphoma, 2007, Volume: 48, Issue:4 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2007
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma. Cancer, 2007, Jun-15, Volume: 109, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome	2007
Metabolic test with fluorine-18-fluorodeoxyglucose in staging and detection of residual tumor or recurrence in Hodgkin lymphoma. Clinics (Sao Paulo, Brazil), 2007, Volume: 62, Issue:2 Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed	2007
Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed? Radiology, 2007, Volume: 244, Issue:1 Topics: Adolescent; Adult; Aged; Biopsy; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2007
The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization c Cancer, 2007, Aug-01, Volume: 110, Issue:3 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; World Health Organization	2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-20, Volume: 25, Issue:24 Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate	2007
Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT. Clinical nuclear medicine, 2007, Volume: 32, Issue:8 Topics: Antineoplastic Agents; Child; Diagnosis, Differential; False Positive Reactions; Female; Femoral Neoplasms; Fibroma; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed	2007
Hodgkin lymphoma: Response assessment by revised International Workshop Criteria. Leukemia & lymphoma, 2007, Volume: 48, Issue:8 Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	2007
Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting? Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2007, Volume: 85, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden	2007
Omitting radiotherapy after attaining FDG PET-negative status following chemotherapy alone for Hodgkin lymphoma: a randomized study caveat. Leukemia & lymphoma, 2007, Volume: 48, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Randomized Controlled Trials as Topic	2007
Avid uptake of [18F]-FDG in fibrous dysplasia can mimic skeletal involvement in Hodgkin's disease. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:1 Topics: Bone and Bones; Child; Diagnosis, Differential; Fibrous Dysplasia, Monostotic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male	2008
Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT. Clinical nuclear medicine, 2007, Volume: 32, Issue:10 Topics: Adult; Chickenpox; Diagnosis, Differential; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy. European journal of haematology, 2007, Volume: 79, Issue:5 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Castleman Disease; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Hyalin; Immunologic Factors; Plasma Cells; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Rituximab; Tomography, X-Ray Computed; Treatment Outcome	2007
FDG-PET scan and treatment planning for early stage Hodgkin lymphoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2007, Volume: 85, Issue:2 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted	2007
FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity. Haematologica, 2007, Volume: 92, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Middle Aged; Pneumonia; Positron-Emission Tomography; Vinblastine	2007
Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET. Archives of medical research, 2008, Volume: 39, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2008
Cervical thymic hyperplasia after chemotherapy in an adult patient with Hodgkin lymphoma: a potential cause of false-positivity on [18F]FDG PET/CT scanning. British journal of haematology, 2008, Volume: 140, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Hyperplasia; Positron-Emission Tomography; Thymus Gland; Tomography, X-Ray Computed	2008
Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult. AIDS (London, England), 2008, Jan-02, Volume: 22, Issue:1 Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Fluorodeoxyglucose F18; HIV Infections; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Thymus Gland; Treatment Outcome; Vincristine	2008
An unusual hotspot in a young woman with Hodgkin's lymphoma. Haematologica, 2008, Volume: 93, Issue:1 Topics: Adolescent; Female; Fluorodeoxyglucose F18; Heart; Hodgkin Disease; Humans; Myocardium; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Radiopharmaceuticals	2008
18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease. Haematologica, 2008, Volume: 93, Issue:1 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphocytes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2008
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2008, Volume: 52, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Bone Marrow; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity	2008
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. The New England journal of medicine, 2008, Feb-14, Volume: 358, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Sarcoidosis; Vinblastine	2008
The evolving standard of care for hodgkin lymphoma. Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:2 Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Positron-Emission Tomography	2008
Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:8 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2008
Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making. International journal of technology assessment in health care, 2008,Spring, Volume: 24, Issue:2 Topics: Carcinoma, Non-Small-Cell Lung; Costs and Cost Analysis; Decision Making; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. La Radiologia medica, 2008, Volume: 113, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in the early diagnosis of asymptomatic bleomycin-induced pneumonitis. Annals of hematology, 2008, Volume: 87, Issue:11 Topics: Adult; Antibiotics, Antineoplastic; Bleomycin; Early Diagnosis; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Pneumonia; Positron-Emission Tomography	2008
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. European journal of nuclear medicine, 1995, Volume: 22, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Drug Resistance, Multiple; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Oxygen Radioisotopes; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Water	1995
FDG-PET for predicting the prognosis of malignant lymphoma. Annals of nuclear medicine, 1994, Volume: 8, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Proportional Hazards Models; Survival Rate; Tomography, Emission-Computed	1994
In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma. Cancer, 1994, Mar-01, Volume: 73, Issue:5 Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Hodgkin Disease; Humans; Insulin; Insulin Resistance; Lymphoma; Male; Middle Aged; Muscles; Tomography, Emission-Computed	1994
Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology, 1994, Volume: 190, Issue:1 Topics: Adolescent; Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1994
Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography. Hormone and metabolic research. Supplement series, 1993, Volume: 27 Topics: Adult; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Granuloma; Hodgkin Disease; Humans; Hyperplasia; Indium Radioisotopes; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Octreotide; Pentetic Acid; Plasmacytoma; Receptors, Somatostatin; Tomography, Emission-Computed	1993
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer, 1993, Jul-01, Volume: 72, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Lung Neoplasms; Male; Middle Aged; Thoracic Neoplasms; Tomography, Emission-Computed	1993
Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:10 Topics: Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Remission Induction; Tomography, Emission-Computed, Single-Photon	1993
Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:3 Topics: Adolescent; Adult; Aged; Algorithms; Biopsy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Health Care Costs; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Tomography, Emission-Computed	1997
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma]. Der Radiologe, 1997, Volume: 37, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Combined Modality Therapy; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Treatment Outcome	1997
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology, 1997, Volume: 203, Issue:3 Topics: Adolescent; Adult; Aged; Biopsy; Child; Contrast Media; Deoxyglucose; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1997
False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:6 Topics: Child; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Thymus Neoplasms; Tomography, Emission-Computed	1997
[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma]. Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:7 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Regression Analysis; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1997
Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology, 1998, Volume: 206, Issue:2 Topics: Adult; Biopsy; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed	1998
Accumulation of FDG in axillary sweat glands in hyperhidrosis: a pitfall in whole-body PET examination. European radiology, 1998, Volume: 8, Issue:3 Topics: Adult; Apocrine Glands; Autonomic Nervous System Diseases; Axilla; Diabetes Mellitus, Type 1; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Groin; Hodgkin Disease; Humans; Hyperhidrosis; Hypoglycemia; Lymph Nodes; Male; Radiopharmaceuticals; Sweating; Tomography, Emission-Computed; Whole-Body Counting	1998
[Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1998, Volume: 168, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Functional imaging of Hodgkin's disease with FDG-PET and gallium-67. Nuklearmedizin. Nuclear medicine, 1998, Volume: 37, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium Radioisotopes; Glucose; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Prednisolone; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine	1998
Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:10 Topics: Adolescent; Adult; Aged; Child; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma. Nuclear medicine communications, 1998, Volume: 19, Issue:11 Topics: Adolescent; Adult; Aged; Blood Glucose; Body Surface Area; Body Weight; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. European journal of nuclear medicine, 1999, Volume: 26, Issue:1 Topics: Adolescent; Adult; Child; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nuclear medicine communications, 1999, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Digestive System; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Liver; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Spleen; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1999
[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients]. Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 1999, Jul-15, Volume: 94, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diagnosis, Differential; Disease-Free Survival; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prognosis; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study. British journal of cancer, 1999, Volume: 80, Issue:3-4 Topics: Adult; Aged; Blood Glucose; Fatty Acids, Nonesterified; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Lipolysis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed	1999
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11 Suppl 1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Positron emission tomography for detection and staging of malignant lymphoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2000, Volume: 156 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
FDG positron emission tomography in lymphoma. Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel, 2000 Topics: Blue Cross Blue Shield Insurance Plans; Device Approval; Drug Approval; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Outcome Assessment, Health Care; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration	2000
The impact of FDG positron emission tomography imaging on the management of lymphomas. The British journal of radiology, 2000, Volume: 73, Issue:869 Topics: Adolescent; Adult; Aged; Contrast Media; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography. Clinical nuclear medicine, 2000, Volume: 25, Issue:10 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
[Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2000
[Post-radiation pneumonitis in a case of Hodgkin's lymphoma assessed with PET-FDG by residual mediastinal mass]. Revista espanola de medicina nuclear, 2000, Volume: 19, Issue:4 Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Radiation Pneumonitis; Radiopharmaceuticals; Tomography, Emission-Computed	2000
Introduction to clinical positron emission tomography. New Jersey medicine : the journal of the Medical Society of New Jersey, 2000, Volume: 97, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed	2000
2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:10 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer, 2001, Jan-15, Volume: 91, Issue:2 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Radiography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed	2001
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica, 2001, Volume: 86, Issue:3 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed	2001
Clinical relevance of positron emission tomography (PET) in treatment control and relapse of Hodgkin's disease. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:3 Topics: Adult; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Predictive Value of Tests; Tomography, Emission-Computed; Treatment Outcome	2001
[Value of positron emission tomography in treatment of lymphoma patients]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:3 Topics: Blood Glucose; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Treatment Outcome	2001
Similar pelvic abnormalities on FDG positron emission tomography of different origins. Clinical nuclear medicine, 2001, Volume: 26, Issue:6 Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Pelvic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed	2001
Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma. Nuklearmedizin. Nuclear medicine, 2001, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed	2001
Pitfalls in imaging Hodgkin's disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:5 Topics: Adult; Animals; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Immunocompromised Host; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Serologic Tests; Splenic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Toxoplasma; Toxoplasmosis	2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood, 2001, Nov-15, Volume: 98, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine	2001
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? British journal of haematology, 2001, Volume: 115, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Patient Selection; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome	2001
Granulocyte colony-stimulating factor: confounding F-18 FDG uptake in outpatient positron emission tomographic facilities for patients receiving ongoing treatment of lymphoma. Clinical nuclear medicine, 2002, Volume: 27, Issue:2 Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease. Annals of hematology, 2002, Volume: 81, Issue:1 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia, 2002, Volume: 16, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation	2002
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. British journal of haematology, 2001, Volume: 115, Issue:4 Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recurrence; Tomography, Emission-Computed	2001
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. The American journal of medicine, 2002, Volume: 112, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2002
Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care. The American journal of medicine, 2002, Volume: 112, Issue:4 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2002
FDG PET in the management of lymphoma: a clinical perspective. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002
False-negative interpretation of FDG positron emission tomography in a patient with Hodgkin's lymphoma. Clinical nuclear medicine, 2002, Volume: 27, Issue:5 Topics: Adult; Axilla; Catheterization, Central Venous; Dose-Response Relationship, Drug; False Negative Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infusions, Intravenous; Lymph Nodes; Time Factors; Tomography, Emission-Computed	2002
Can (18)F-FDG PET after first cycle chemotherapy predict the efficacy of therapy in Hodgkin's disease? Haematologica, 2002, Volume: 87, Issue:5 Topics: Antineoplastic Agents; Feasibility Studies; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Predictive Value of Tests; Tomography, Emission-Computed; Treatment Outcome	2002
Bleomycin-induced alveolitis detected by FDG positron emission tomography. Clinical nuclear medicine, 2002, Volume: 27, Issue:7 Topics: Adult; Aged; Bleomycin; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Pulmonary Fibrosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals	2002
[Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Malignant lymphoma]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2002, Volume: 62, Issue:6 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
[The role of PET scan in the investigation of the lymphatic spreading of Hodgkin's disease]. Orvosi hetilap, 2002, May-26, Volume: 143, Issue:21 Suppl 3 Topics: Adult; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. European journal of nuclear medicine, 1992, Volume: 19, Issue:5 Topics: Adult; Deoxyglucose; Fluorodeoxyglucose F18; Gamma Cameras; Hodgkin Disease; Humans; Middle Aged; Myocardial Infarction; Thallium Radioisotopes; Tomography, Emission-Computed	1992
Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cell Division; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Nuclear Proteins; Tomography, Emission-Computed	1992
The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Tomography, Emission-Computed	1991